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SUMMARY 
Urogenital tract infections are a major health problem among women. These infections 
include sexually transmitted diseases such as gonorrhoeae, chlamydia, syphilis and acquired 
immunity deficiency syndrome (AIDS) (Parratt and Hay, 2003), as well as opportunistic 
urogenital infections such as vaginosis and abnormal urinary tract infections (Foxman, 2003; 
Sobel and Chaim, 1996; Wang, 2000). Vaginosis and urinary tract infections affect more 
than 1 billion women worldwide annually (Reid and Bruce, 2003). Antibiotic resistance and 
the public demand for natural products have shifted the focus towards the application of 
probiotic lactic acid bacteria to try and combat these infections. 
Probiotics are marketed as microbial food supplements or capsules that may prevent 
diseases and clinical disorders (Schrezenmeir and de Vrese, 2001 ). Most of the well-known 
probiotics are lactic acid bacteria and include species such as Lactobacillus rhamnosus GR-
1 and Lactobacil/us fermentum RC-14 (Hoesl and Altwein, 2005; Stiles and Holfzapel, 1997). 
Many of these bacteria are natural inhabitants of the urogenital tract which they colonize to 
form a protective barrier against intestinal pathogens (Hoesl and Altwein, 2005; Song et al., 
1999). Some probiotic strains produce antimicrobial peptides (bacteriocins ), usually with a 
narrow spectrum of activity, i.e. inhibition of only a certain group of pathogens 
(Klaenhammer, 1993). 
Bacteriocins are secreted either through ATP-binding cassettes (ABC) - transporters or via a 
general secretion pathway. Bacteriocins secreted by ABC-transporters have a double-
glycine-type leader sequence in their N-terminal, which serves as a recognition signal for 
protein procession and secretion (Haverstein et al., 1995). A sec-dependent leader signal 
peptide is characteristic of bacteriocins secreted through the general secretion pathway. The 
sec-dependent leader peptide is usually positively charged with a hydrophobic core and a 
specific cleavage region (von Heijne and Abrahmsen, 1989). 
In this study, lactic acid bacteria were screened for the production of bacteriocins active 
against uropathogenic strains of Enterococcus faecalis and Candida albicans. Enterococcus 
faecalis is usually associated with secondary bacteraemia of the urogenital tract and is linked 
to a large number of hospital-acquired infections. Human immunodefiency virus (HIV) 
patients are especially susceptible to E. faecalis infections. Candida albicans, on the other 
hand, is an opportunistic pathogen responsible for 80-90% of reported cases of candidal 
vaginosis, which is diagnosed in approximately 75% of women (Sobel, 1993). Approximat-e1y 
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half of the patients suffering from candidal vulvovaginitis (CW) suffer from follow-up 
infections (Ferrer, 2000). 
Strain TB, isolated from vaginal secretions of children infected with HIV, inhibited the growth 
of uropathogenic strains of E. faeca/is and was identified as an Enterococcus faecium 
isolate. Two additional strains, Lactobacil/us plantarum 423 and Enterococcus mundtii ST15, 
isolated from sorghum beer and soy flour, respectively, also inhibited E. faecalis and were 
included in the study. None of the three strains produced hydrogen peroxide. All three 
strains produced bacteriocin-like peptides that inhibited E. faecalis. 
Plantaricin 423, produced by L. plantarum 423, has been described previously (van Reenen 
et al., 199B) and is similar to pentocin TV35b (Okkers et al., 1999). Bacteriocin ST15, 
produced by Enterococcus mundtii ST15, is similar to mundticiin ST 4SA produced by a 
different strain of E. mundtii (Knoetze, Department of Microbiology, University of 
Stellenbosch, personal communication). Bacteriocin TB, produced by E. faecium TB, is a 
class I la sec-dependent bacteriocin and may be considered a novel peptide produced by 
enterococci. The operon containing the structural gene, a potential immunity gene and 
mobilization genes is located on a 7 kb-plasmid . The operon was sequenced and the mode 
of activity of bacteriocin TB determined. Bacteriocin TB is 69% homologous to bacteriocin 
31, produced by Enterococcus faecalis Y1717 (Tomita et al., 1996). The signal peptide of 
bacteriocin TB is only 27% homologous to the signal peptide of bacteriocin 31. The immunity 
peptide of bacteriocin TB displayed 50% homology to that of bacteriocin 31. 
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OPSOMMING 
Urogenitale infeksies is 'n groat gesondheidsprobleem onder vroue. Hierdie infeksies sluit in 
seksuele oordraagbare siektes soos gonorree, chlamydia, sifilis en verworwe 
immuniteitsgebreks sindroom (VIGS) (Parratt en Hay, 2003), asook opportunistiese 
urogenitalie infeksies soos vaginose en abnormale urinekanaal infeksies (Foxman, 2003; 
Sobel en Chaim, 1996; Wang, 2000). Vaginose en urinekanaal infeksies affekteer meer as 1 
biljoen vroue jaarliks wereldwyd (Reid en Bruce, 2003). Weerstand teen antibiotika en die 
publieke vraag na natuurlike produkte plaas die fokus op probiotika vir die bevegting van 
hierdie infeksies. 
Probiotika word bemark as mikrobiese voedsel-supplemente of kapsules wat siektes en 
kliniese kondisies kan voorkom (Schrezenmeir en de Vrese, 2001 ). Meeste van die bekende 
probiotika is melksuurbakteriee en sluit spesies soos Lactobacil/us rhamnosus GR-1 en 
Lactobacillus fermentum RC-14 in (Hoesl en Altwein, 2005; Stiles en Holfzapel, 1997). Baie 
van hierdie bakteriee is natuurlike inwoners van die urogenitale weg waar hulle koloniseer 
om 'n beskermende versperring te vorm (Hoesl en Altwein, 2005; Song et al., 1999). 
Sommige probiotiese stamme produseer antimikrobiese peptiede (bakteriosiene), maar 
gewoonlik met 'n beperkte spektrum van aktiwiteit, m.a.w. slegs sekere patogene word ge-
inhibeer (Klaenhammer, 1993). 
Bakteriosiene word met behulp van ATP-bindende kaset (ABK)- vervoerders of 'n meer 
algemene sekresie-metode uitgeskei. Bakteriosiene wat deur ABK-vervoerders uitgeskei 
word besit 'n dubbel-glisien leiertipe volgorde in hul N-terminaal wat as 'n herkenningsetel vir 
prote'len-prosessering en sekresie dien (Haverstein et al., 1995). 'n Sec-afhanklike leiersein-
peptied is kenmerkend van bakteriosiene wat deur die algemene sekresie-pad uitgeskei 
word. Die sec-afhanklike leier-peptied is gewoonlik positief gelaai en het 'n hidrofobiese kern 
en klewing area (von Heijne and Abrahmsen, 1989). 
In hierdie studie is melksuurbakteriee vir die produksie van bakteriosiene aktief teen 
patogene stamme van Enterococcus faecalis en Candida albicans geselekteer. 
Enterococcus faecalis is gewoonlik geassosieer met sekondere bakteraemia en is gekoppel 
aan 'n groot aantal hospitaal-verwante infeksies. Mens immuniteitsgebrek virus (MIV)-
pas'lente is veral vatbaar vir E. faecalis infeksies. C. albicans, aan die anderkant, is 'n 
opportunitiese patogeen wat vir 80 tot 90% van gerapporteerde gevalle van kandidale 
vaginose verantwoordelik is (Sobel, 1993). Simptome hiervan is in soveel as 75% van 
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gevalle aangeteken. Omtrent helfte van die pas·iente wat aan kandidale vulvovaginitis lei 
ervaar verdere infeksies (Ferrer, 2000). 
Stam TB, ge'isoleer uit vaginale sekresies van kinders ge'infekteer met MIV, het die groei van 
patogene stamme van E. faecalis geinhibeer. Stam TB is as Enterococcus faecium ge-
identifiseer. Twee addisionele stamme, Lactobacillus plantarum 423 en Enterococcus 
mundtii ST15, ge·isoleer van sorgumbier en sojameel, onderskeidelik, het ook E. faecalis 
geinhibeer en is in hierdie studie ingesluit. Nie een van hierdie stamme produseer 
waterstofperoksied nie. Die drie stamme produseer bakteriosien-verwante peptiede wat die 
groei van E. Faecalis inhibeer. 
Plantaricin 423, geproduseer deur L. plantarum 423, is deur van Reenen et al. (199B) beskryf 
en is soortgelyk aan pentocin TV35b (Okkers et al., 1999). Bakteriosien ST15, geproduseer 
deur Enterococcus mundtii ST15, is soortgelyk aan mundticiin ST 4SA wat deur 'n ander E. 
mundtii stam geproduseer word (Knoetze, Departement Mikrobiologie, Universiteit van 
Stellenbosch, persoonlike kommunikasie). Bakteriosien TB, geproduseer deur Enterococcus 
faecium TB , is 'n nuwe klas Ila sec-afhanklike bakteriosien. Die operon wat die strukterele 
geen, 'n potensiele immuniteits-geen en mobiliseringsgene bevat, is op 'n 7 kb plasmied 
gelokaliseer. Die operon se DNA volgorde en die meganisme van werking van die 
bakteriosien is bepaal. Bakteriosien TB is 69% homoloog aan bakteriosien 31, geproduseer 
deur Enterococcus faecalis Y1717 (Tomita et al., 1996). Die sein-peptied en 
immuniteitsprote'ien van bakteriosien TB is onderskeidelik slegs 27% en 50% homoloog aan 
die ooreenstemmende peptiede van bakteriosien 31 . 
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PREFACE 
The literature study is an overview of infections occurring in the urogenital tract. Probiotics, 
with the emphasis on strains used in the urogenital tract, and their bacteriocins are also 
discussed. 
The articles "Screening of lactic acid bacteria for antimicrobial activity against Enterococcus 
faeca/is and Candida albicans isolated from patients diagnosed with vaginosis" and 
"Bacteriocin TB, a novel class Ila sec-dependent bacteriocin produced by Enterococcus 
faecium TB, isolated from vaginal secretions of children infected with HIV" are written 
according to the style of Applied and Environmental Microbiology. 
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INTRODUCTION 
Non-sexually and sexually transmitted infections in the urogenital tract affect billions of women 
worldwide (Hoes! and Altwein, 2005; www.avert.org/statisticsworldwide.htm). Failure to treat 
these infections may lead to pyelonephritis (kidney infection). premature delivery, infertility, 
fetal mortality, impaired renal function , pelvic inflammatory diseases, cercival cancer and even 
death (Foxman , 2003; Jung et al., 2004; Martin et al., 1999; Parratt and Hay, 2003; Rhoton-
Vlasak , 2000 ; Romero et al., 2004). Treatment of urogenital tract infections is complicated by 
the spread of antibiotic resistance amongst uropathogens . Resistance to antibiotics is 
developed through mutations and the transfer of resistance genes to other microorganisms. 
The use of broad-spectrum drugs, the high frequency of infected people in hospitals, the 
prolonged stay in hospitals and intensive care units, and the abuse of antibiotics in the 
treatment of farm animals are contributing to the spread of antibiotic resistance (Hancock, 
2005). A few antibiotics are used in the treatment of vancomycin-resistant enterococci, 
including Enterococcus faecalis that causes urinary tract infections (Tenover and McDonald, 
2005) . Multi-drug resistant uropathogens such as Candida albicans (Prasad and Kapoor, 
2005), Neisseria gonorrhoeae , Escherichia coli (levy, 2005) , Gardenella vagina/is and 
Chlamydia trachomatis (Ruef, 2005) are also emerging. Most of the latter species form 
biofilms, which renders them inaccessible to antibiotics (Greiner et al., 2005; Mukherjee et al., 
2005; Swidsinski et al. , 2005; Tendolkar et al., 2005). 
The trend to use natural products in the treatment of urogenital tract infections, as well as 
increased antibiotic resistance, has shifted the focus towards probiotics as a possible 
alternative means of therapy . Probiotic foods and supplements are worth an estimated US $6 
billion annually . Currently , Lactobacil/us rhamnosus GR-1 and Lactobacillus fermentum RC-14 
are marketed as oral supplements for the treatment of urogenital tract infections (Hoes! and 
Altwein , 2005). The latter two strains have undergone intensive tests for safety and 
effectiveness (Reid et al., 2001a; Reid et al., 2001b; Reid et al., 2003). Lactic acid bacteria 
inhibit the growth of uropathogens by production of lactic acid, hydrogen peroxide and 
antimicrobial peptides (bacteriocins) . For these bacteria to successfully compete with 
pathogens, they need to colonize the urogenital tract and form a barrier against invading 
microorganisms (Reid, 1999). 
In this study, lactic acid bacteria were screened for the production of bacteriocins inhibitory 
towards uropathogens. Selected strains were also studied for probiotic properties. A novel 
class Ila sec-dependent bacteriocin, produced by Enterococcus faecium strain TB, is 
described. 
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1. INFECTIONS OF THE UROGENITAL TRACT 
1. 1. Introduction 
Infections of the urogenital tract affect millions of women. Some of the opportunistic pathogens, 
such as Candida albicans, Gardenere//a vagina/is and Escherichia coli cause a variety of 
diseases, including candidal vulvovaginitis (CW), bacterial vaginosis (BV) and urogenital 
infections (Foxman, 2003; Sobel and Chaim, 1996; Wang, 2000) . Infections caused by sexually 
transmitted pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema 
pallidum and the human immunodefiency virus (HIV) are classified as sexually transmitted 
diseases (Parrat and Hay, 2003) . 
Candida! vulvovaginitis is associated with antibiotic therapy, pregnancy, uncontrolled diabetes, 
estrogen therapy, and the use of oral contraceptions with high levels of estrogen. Candida! 
vulvovaginitis can develop into recurrent symptomatic episodes of vaginitis or even chronic CW 
(Sobel and Chaim, 1996). 
Bacterial vaginosis (BV) is the most common cause of vaginitis , affecting over three million 
women in the Unites States annually (Wang, 2000). Bacterial vaginosis is characterized by a 
decrease of the normal population of lactobacilli in the vagina, associated with an overgrowth of 
anaerobic and facultative anaerobic microorganisms (Eschenbach et al., 1989; Hill , 1993; 
Kimerlin and Andrews , 1998). This disease has been reported in 15 to 20% of pregnant women 
(Eschenbach et al., 1984; McGregor and French, 2000) and has been associated with 
spontaneous preterm delivery (Eschenbach et al., 1984), premature rapture of membranes 
·(Lamont, 2003), and postpartum endometritus (Eschenbach et al., 1984). 
Urinary tract infection (UTI) is the most common nosocomial bacterial infection and is caused by 
Enterobacteriaceae and Enterococcus spp. The infection increases the risk of pyelonephritis 
(kidney infection) and may lead to premature delivery, often fetal mortality . Other symptoms are 
impaired renal function and end-stage renal disease, especially in pediatric patients (Foxman, 
2003) . 
Sexually transmitted disease (STD), also known as Sexually Transmitted Infection (STI) , is 
associated with pelvic inflammatory disease, infertility, ectopic pregnancy, cervical cancer, 
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neonatal infections and even death (Parratt and Hay, 2003) . Sexually transmitted diseases are 
divided into two groups based on teratability . Infections caused by N. gonorrhoeae, C. 
trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and T. pallidum are curable and 
belongs to the first group. Viral infections, especially HIV, human papillomavirus (HPV) , hepatitis 
B/C virus (HBV, HCV), cytomegalo virus (CMV) and herpes simplex virus (HSV) are incurable 
(Schneede et al., 2003). Infections caused by C. trachomatis, N. gonorrhoeae and T. pal/idum 
are discussed in the following sections. 
1. 2. Microbiology 
C. afbicans is a unicellular, eukaryotic yeast. The colonies are cream-colored to yellowish . The 
texture of the colonies varies , depending on the species and may be pasty, smooth, glistening or 
dry, wrinkled and dull. Variations in morphology are common (Eggimann et al., 2003). Candida 
is a dimorphic fungus present in two states. Blastospores and spores are the phenotype for 
extension, dissemination and transmission. Mycelium is the phenotype for germination (Ferrer, 
2000) . 
BV is caused by G. vagina/is ; Gram-negative anaerobic rods such as Prevotella spp.; Gram-
positive anaerobic cocci , such as Peptostreptococcus spp.; genital mycoplasmas (M. hominis 
and Ureaplasma urealyticum) ; and curved Gram-positive anaerobic rods, e.g. Mobiluncus spp. 
G. vagina/is is, however, considered the main causative agent of BV (Hill , 1993). 
Pathogens involved in UTls are Enterobacteriaceae, Proteus mirabi/is, Klebsiel/a spp., 
Staphylococcus saprophyticus, enterococci and Pseudomonas spp. E. coli is the predominant 
species , although Enterococcus faecalis is considered an important pathogen (Kahlmeter, 2003; 
Preston et al., 1992; Reid and Seidenfeld, 1997). 
Chlamydia trachomatis is the causative agent of chlamydia. These Gram-negative, obligate 
intracellular bacteria infect eukaryotic cells, but differ from other intracellular parasites in that 
they are not primarily parasites of invertebrates and have a biphasic cycle of replication 
(Cevenini et al., 2002; Oehme et al., 1991). N. gonorrhoeae causes gonorrhoea. This highly 
infectious, Gram-negative intracellular aerobic diplococcus, colonizes mucosa! surfaces of the 
urogenital tract and the large intestine (Ghosn and Kibbi , 2004). Syphilis is caused by the 
spirochete T. pallidum. Humans are the only natural host of T. palfidum, although the species 
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can be propagated in the testis and skin of rabbits (Cox et al., 2003; Deka et al., 2002). The cell 
has an outer membrane similar to those of Gram-negative bacteria, but lacks 
lipopolysaccharides. The cell wall structure is more related to Gram-positive bacteria. Located in 
the periplasmic space is a contractible endoflagella (Cox et al., 2003). 
1. 3. Epidemiology 
C. albicans is one of approximately 200 Candida spp. and belongs to genus 4 in the family 
blastomycetes. C. albicans is the most frequently isolated yeast from colonized and infected 
sites in humans and is associated with 80 to 90% of reported cases of vaginal candidiasis 
(Sobel , 1993). Candida glabrata is the second most commonly isolated species (5 to 15% of 
reported cases) , followed by Candida tropicalis, Candida pseudotropicalis and Candida krusei 
(Spinillo et al., 1995). Candida! vulvovaginitis affects 75% of women during their life span , and 
approximately half of them suffer a second CW event. Recurrent CW develops in 5% of the 
cases, showing frequent and refractory episodes (Ferrer, 2000). 
BV affects over three million women in The United States of America annually (Wang, 2000). 
BV has been reported in 1 O to 25% of patients that visit general gynaecologic and obstetrics 
clinics. The statistics increases to 64% in sexually transmitted disease clinics (Sobel , 2000; 
Wang, 2000) . BV has also been diagnosed in as many as 15 to 20% pregnant women 
(Eschenbach et al., 1984; Sobel, 2000). 
Women are more likely to suffer from UTls than men. According to Foxman et al. (2000), one in 
three women will have at least one UTI diagnosed by a clinical physician before the age of 24. 
F.ifty percent of the women diagnosed with UTI developed recurrent UTls within the first year 
(Hooton, 2001 ). Catheter-associated UTls are the most common nosocomial infections. A study 
conducted in 1992 indicated that 40% of all nosocomial infections were caused by catheters 
(Hashmi et al., 2003). In non-institutionalized patients, UTls accounts for nearly 25% of all 
infections (Raz, 2001 ). 
E. faecalis is more frequently detected than E. coli amongst hospitalized patients (Hampel et al., 
2d03) . According to a study performed in intensive care units in Spain, enterococci are present 
in 10.2% of ICU-acquired infections. Enterococci, with E. faecalis being the predominant 
uropathogen, manifest as UTls and secondary bacteraemia (Lerma et al., 2003). E. faecalis 
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was also the most prevalent pathogen isolated from UTI patients over a period of 20 years 
(Shigemura et al., 2005) . Enterococcus spp. are the predominant bacteria isolated from HIV-
patients suffering from urinary tract infections (Schonwald et al. , 1999). 
According to the World Health Organisation (WHO), 340 million new cases of STDs have been 
reported in 1999. The largest number of new infections occurred in South and Southeast Asia, 
followed by Sub-Sahara Africa, Latin America and the Caribbean. Chlamydia! infections 
increased between 1995 and 1999 with an estimated 2.5 million cases worldwide. In Sub-
Sahara Africa 40.48 million infections have been reported in 1995, compared to 42.89 million in 
1999. An estimated 62 million cases of gonorrhoea have been reported in 1999. During this 
period prevalence rates in Sub-Sahara Africa increased, while there was a decrease in other 
parts of the world. Cases of infection increased from 15.67 million in 1995 to 17.03 million in 
1999. An estimated 12.22 million cases of syphilis have been reported worldwide in 1999, with a 
prevalence of 8.4 % in South Africa. The occurrence of all three infections is higher among 
women (www.avert.org/statisticsworldwide.htm) . 
1. 4. Pathogenesis and the virulence factors involved 
C. albicans follows a three-stage invasion mechanism. In each stage different virulence factors 
promote successful invasion . Adherence of C. albicans to vaginal epithelial cells is the first stage 
of infection and is necessary for blastospore survival and colonization . Adhesion of C. albicans 
is much higher compared to that of C. glabrata, C. tropicalis, C. pseudotropicalis and C. krusei. 
This explains the higher frequency of C. albicans infections in clinical settings (King et al., 1980). 
Candida spp. recognize phospholipid- and fibronectin-containing receptors in the cell 
membranes of the vaginal epithelium. Blastospore adherence is dependent on mannoproteins in 
the fungal membrane. These proteins anchor itself to the receptors on the surface cells in the 
vaginal epithelium (Matthews and Burnie, 1998). The agglutinin-like sequences (ALS) are 
members of another family of adhesions that contribute to virulence in C. albicans (Hoyer, 2001) . 
Blastospores are not capable of penetrating epithelial tissue. However, once mycelium has 
developed, the yeast penetrates and invades the vaginal surface cells . A number of exogenous 
factors promote germination and mycelium or hyphae development (Ferrer, 2000) . Penetration 
of epithelial cells is mediated by the production of several proteases (Ferrer, 2000) . Proteases 
~ave also been implicated in phagocytosis. The phagolysosome produces proteinase after 
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germination of the ingested yeast. Proteinase attacks the proteins involved in the generation of 
microbicidal oxygen radicals , causing death of the phagocyte (Borg and Ruchel , 1990). 
Phospholipases have also been implicated in the virulence of C. albicans. Epithelial invasion 
causes the release of several substances, such as prostaglandins and bradykinins, inducing 
inflammatory changes in tissues. This process leads to edema, erythema, increased exudates, 
and cell shedding (Ferrer, 2000) . 
Phenotypic switching is a virulence factor enabling C. a/bicans to generate phenotypes that are 
beneficially adapted to different host environments. Phenotypic traits affected by this switching 
are cell morphology, lipid and sterol content, levels of protease secretion , hyphae formation , 
antigen expression and susceptibility to antifungal agents (Matthews and Burnie , 1998). 
Anaerobic organisms such as Bacteroides species, Prevotel/a bivius, and Peptostreptococcus 
spp., as well as facultative anaerobic/aerobic organisms such as G. vagina/is, Staphylococcus 
epidermis and streptococci, constitutes 5% of the normal vaginal microflora (Kimerlin and 
Andrews, 1998). Lactobacilli account for the other 95%, as previously discussed. Reduction of 
the dominant lactobacilli (Eschenbach et al., 1989; Hawes et al., 1996) and overgrowth of 
anaerobic and facultative anaerobic organisms are implicated in BV (Hill , 1993; Kimerlin and 
Andrews, 1998). 
Reduction of lactobacilli results in an increase in pH, which favours the growth of G. vagina/is. G. 
vagina/is decreases the oxygen level , which promotes growth of anaerobic bacteria and an 
increase in the production of proteolytic carboxylase enzymes (Wang, 2000) . These enzymes 
break down vaginal peptides to a variety of amines such as trimethylamine, which at high pH, 
becomes volatile and malodorous. The amines are associated with increased vaginal 
transudation and squamous epithelial cell exfoliation, creating a typical discharge. Clue cells are 
created in conditions of elevated pH when G. vagina/is adheres to exfoliating epithelial cells. 
Amines provide a suitable substrate for the growth of M. hominis (Sobel , 2000). Although studies 
have shown that G. vagina/is and other BV-associated organisms may be transferred sexually, 
transmission alone is not sufficient for infection. The latter organisms are present in low numbers 
in a healthy vagina (Sobel , 2000). 
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Most uropathogens enter the bladder via the urethra and rectum. Vaginal colonization is a 
prerequisite to bladder infection. Uropathogens stimulate the release of cytokines in the bladder 
or kidneys , resulting in an inflammatory response and symptoms of UTI (Hooton, 2000). 
Uropathogenic strains with certain virulence determinants have a selective advantage with 
regard to colonization and infection. Surface glycoproteins in the form of fimbriae or pili serve as 
ligands for glycoprotein and glycolipid receptors on uroepithelial cells . Type 1- and P-fimbriated 
strains of E. coli are strongly associated with cystitis and pyelonephritis (Johnson, 1991 ). 
Clinical evidence for the pathogenic role of P- and type 1-fimbriae in persistent bladder 
colonization and recruitment of inflammatory response have been published (Wullt, 2003). 
Potassium or capsular antigens, which inhibit phagocytosis, and the aerobactin system that 
chelates urinary iron, act as virulence factors by offering a growth advantage (Wullt, 2003) . 
C. trachomatis serovars D-K are responsible for genital chlamydia infections (Persson, 2002) . 
During its unique developmental cycle, the bacteria alternate between two structurally and 
physiologically distinct forms. The one form , the elementary bodies (EB) , is a stable structure, 
which remains viable extracellularly. The EB infect mainly epithelial cells and re-organizes to 
form metabolically active reticulate bodies (RB) . DNA, RNA and protein are synthesized within 
the RB. This leads to binary fission and the transformation of RB into infectious EB. The EB are 
released within 48-72 hours and remain viable for a limited period before they infect other 
epithelial cells (Oehme et al., 1991 ; Paavonen , 2004). The C. trachomatis heat shock protein 
(Hsp70) plays an important role in the interaction of EB to host cell ligands (Raulston et al. , 
2002) . 
Syphilis is transmitted usually through sexual contact. T. pallidum infects the host through 
mucosal membranes and minor abrasions in the skin and replicates locally. A chancre appears 
at the primary site of inoculation. T. pallidum replicates very slowly with a generation time of 
approximately 33 hours. This explains the long-drawn-out nature of the illness and the relatively 
long incubation period (Zeltser and Kurban , 2004) . T. pallidum induces endoarteritis by the 
binding of the spirochetes to endothelial cells and is facilitated by fibronectin molecules bound to 
the surface of spirochetes (Thomas et al., 1986). No virulence factors have been described for 
T. pallidum. Weinstock et al. (1998) described 67 genes believed to be involved in interaction 
with the host. 
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Pili (thin, filamentous cell appendages) are essential for N. gonorrhoeae to infect the host. This 
type-4 pilus system attaches the organism to human epithelial cells (Fussenger et al., 1997). 
The Opa-associated (class 5) proteins are outer membrane proteins with a molecular weight of 
approximately 28 kDa. These proteins are each encoded by an opa gene and are expressed by 
most strains of N. gonorrhoeae. It is speculated that these proteins play a role in invasion of 
epithelial cells following initial pili-mediated attachment. Once in the subepithelial space, they 
induce an inflammatory response (Nassif et al., 1999). 
Porins are another important virulence factor. N. gonorrhoeae produces two porins encoded by 
the genes porA and porB. Neisserial porins translocate as functional voltage-gated ion channels 
into the plasma membranes of eukaryotic cells . This causes a change in membrane potential 
and interferes with cell signalling (Ulmer et al. , 1992). Furthermore, porB plays a role in the 
invasion of epithelial cells (Bauer et al., 1999). lgA 1 protease also plays an important part in the 
pathogenesis of N. gonorrhoeae. lgA 1 protease achieves this by cleaving the LAMP1 protein 
and therefore preventing phagolysosome fusion (Lin et al., 1997). 
1. 5. Host predisposing factors and risk factors 
Pregnant women have a higher risk of developing CW. During pregnancy there is an increased 
vaginal susceptibility to infection, with a high rate of colonization and symptomless vaginitis 
(Sobel, 1993). The high estrogen levels leads to increased glycogen concentrations in the 
epithelium, which is a nutritional source for yeast growth. Gestational hyperestrogenism 
promotes fungal adhesion and germination and, as a consequence, fungi are more capable to 
penetrate the vaginal wall (Zhang et al., 2000) . Oral contraceptives contain high levels of 
estrogen, which leads to increased candidal colonization . The mechanisms are the same as in 
pregnancy (Denning et al., 1995). Metabolical disturbances in diabetic women predispose them 
to CW. Appropriate diabetic control can minimize this factor (Reed, 1992). Candida! 
vulvovaginitis commonly occurs after systematic or vaginal antibiotic treatment. Antibiotic agents 
suppress lactobacilli , leading to the growth, adherence and germination of Candida spp. 
(Bluestein et al., 1991 ). 
Normal vaginal microflora, especially Lactobacillus spp., have been implicated in preventing 
vulvovaginitis (Hillier et al., 1992). Lactobacilli compete with yeast for nutrients and block 
epithelial receptors for blastospore adhesion through co-aggregation (Klebanoff et al. , 1991). 
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However, the number of lactobacilli adhering to patients with CW is higher than in the control 
group. This suggests that lactobacilli do not play a protective role against C. albicans 
(Demirezen, 2002) . This suggestion is supported by a study in which the use of oral or vaginal 
lactobacilli preparations were unsuccessful in preventing post-antibiotic CW (Pirotta et al., 
2004). Furthermore, in another study, lactobacilli were the predominant flora in both healthy 
asymptomatic women and women with acute recurrent CW (Sobel and Chaim, 1996). 
The frequency of BV is higher among women with multiple sexual partners (Hay et al., 1997) 
and women visiting STD clinics (Cohen et al. , 1995). BV is also higher among lesbian women 
and women whose male partners have urethritis (Schmid, 1999). The treatment of partners to 
lower the risk of transmission has to be proven in therapy studies . Although this suggests that 
BV is associated with sexual activity, it is not a STD as stated before (Sobel , 2000). Women with 
black ethnicity have higher rates of BV than other racial groups (Goldenberg et al., 1996). The 
use of intra-uterine device (IUD) is another risk factor for BV. Researchers have shown that IUD 
use is higher among women with BV than women without BV (Amsel et al., 1983). The role 
douching plays in contracting BV is uncertain, although Hawes and co-workers have reported an 
association (Hawes et al., 1996). The presence of H20rproducing lactobacilli has been 
associated with a decreased risk of developing BV (Eschenbach et al., 1989; Hillier et al., 1993; 
Klebanoff et al., 1991 ; Nagy et al., 1991 ; Wilks et al., 2004) . 
Risk factors for UTls in young women includes the following : Sexual intercourse, having a new 
sex partner during the past year, spermicidal use, a history of recurrent UTI , having a mother 
with a history of UTls and having a first UTI at or before 15 years of age (Hooton et al., 1996). 
The use of spermicides and antimicrobial agents are also important risk factors . Nonoxynol-9, 
the active ingredient in most spermicidal compounds, and antimicrobial agents disturb the 
natural microflora of lactobacilli in the urogenital tract. This in turn increases the colonization of 
uropathogens (Herthelius-Elman et al., 1992; McGregor et al., 1990; Winberg et al., 1993). In a 
large case-control study of more than 450 women, the strongest risk factor for recurrent UTI in a 
multivariate analysis was the frequency of sexual intercourse. In the same study, 47% of the 
women had a maternal history of UTI and 22% had their first UTI episode before the age of 24. 
These variables were associated with a two-to four-fold increase in risk of recurrent UTls and 
were the most strongly associated variables after sexual intercourse (Scholes et al., 2000). 
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Inherited factors may play an important role in the occurrence of UTls. Women with recurrent 
UTls are three to four times more likely non-secretors of histo-blood group antigens than women 
without UTls. Uropathogenic E. coli adheres better to epithelial cells of women who are non-
secretors than to cells of secretors (Kinane et al., 1982; Sheinfeld et al., 1989). This could be 
due to the fact that epithelial cells of non-secretors selectively express globoseries glycolipid 
receptors to which E. coli binds. This is presumably due to sialylation of the gal-globoside 
precursor glycolipid, which in secretors is fucosylated and processed to ABH antigens 
(Stapleton, 1992). Another hereditary factor that may predispose women to UTI is the 
interleukin-8 receptor (IL-8R), CXCR1. lnterleukin-8 is an inflammatory cytokine that promotes 
neutrophil migration across the infected uroepithelial cells (Godaly et al., 1997). This was 
demonstrated in experiments where mice lacking the CXCR1 gene were unable to clear bacteria 
from the kidney and eventually developed bacteraemia. In addition, a preliminary analysis of 
interleukin-8 expression on the neutrophils of children with pyelonephritis has shown a defective 
version of CXCR 1, which may explain their susceptibility to recurrent pyelonephritis (Finer and 
Landau, 2001 ). 
The reduced levels of estrogen in postmenopausal women predispose them to UTls. Topically 
applied intravaginal estrogen normalized the vaginal microflora and reduced the incidence of 
recurrent UTls (Raz and Stamm, 1993). Mechanical and physiological factors that affect bladder 
emptying are strongly associated with recurrent UTls in postmenopausal women, in contrast to 
the behavioural risk factors described for premenopausal women. Urinary incontinence, 
presence of a cystocele, and post-voiding residual urine are all urological factors associated with 
recurrent UTls (Raz et al., 2000) . In postmenopausal women there is also a decrease in 
lactobacilli numbers. The presence of lactobacilli in postmenopausal women is associated with a 
lower frequency of vaginal colonization with Enterobacteriaceae (Altoparlak et al., 2004) . 
Treatment with lactobacilli to prevent the re-occurrence of UTls yielded positive (Reid et al., 
1992; Asa hara et al., 2001) and negative results (Baerheim et al., 1994). The role lactobacilli 
play in protecting the urogenital tract against UTls is still not clear. 
The prevalence of STDs is higher among adolescents . Adolescents are not only more 
susceptible to STDs because of their sexual behaviour, but biological and immunological 
characteristics also play a role. Women with a greater number of sexual partners are more likely 
to experience STDs. Lack of condom use, and the abuse of alcohol, tobacco and drugs are 
identified as risk factors for STDs (Manhart et al., 2004; Norman, 2002; Taquette et al., 2004) . 
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The absence of vaginal lactobacilli has been associated with an increased risk of acquiring HIV-
1 infection and gonorrhea (Martin et al., 1999; Mbizvo et al., 2001 ; van de Wijgert et al., 2000). 
BV has also been associated with a higher frequency of HIV-1 acquisition (Schwebke, 2001 ; 
Sewankambo et al., 1997). Other researchers have found no association between BV and HIV-1 
acquisition , contradicting previous research (Demba et al., 2005) . 
1. 6. Clinical features, diagnosis and treatment 
Symptoms of CW include vaginal discharge, vulvar burning, dyspareunia, and external dysuria 
(Ward, 2002). CW is diagnosed by microscopic examination of a saline wet-mount preparation 
and a potassium hydroxide preparation, and a litmus test for the pH of vaginal secretions (Egan 
and Lipsky, 2000) . These tests are not very reliable due to poor sensitivity and lack of specific 
clinical signs (Sobel, 1997). Fluconazole is a triazole agent that is used as first-line management 
option for the treatment and prophylaxis of both localized and systematic C. albicans infections. 
Fluconazole is the drug of choice because of its well-known efficacy and safety profile, its 
relatively low costs , and suitability for children , the elderly and people with impaired immunity. 
ltraconazole is an antifungal with a wider spectrum and is used when treatment with fluconazole 
fails (Martin, 1999). 
An unpleasant "fishy-smelling" discharge is the most common symptom of BV. The discharge is 
off-white, thin and homogenous. Erythema and inflammation are usually absent. Most women 
with BV are asymptomatic (Famulare et al., 2001 ; Sobel, 2000) . BV is diagnosed using the 
criteria established by Amsel and his co-workers. This requires identifying three of the following 
four signs: (1) The presence of clue cells , (2) a homogenous, non-inflammatory discharge that 
adheres to the vaginal walls , (3) an elevated pH of greater than 4.5, and (4) a positive 
whiff/amine test (Amsel et al., 1983). The presence of clue cells is the most rel iable predictor of 
BV. Vaginal gram stain is more reliable than wet mount and also serves as permanent record 
(Nugent et al., 1991 ). Cultures are non-specific because G. vagina/is also resides in normal 
vaginal flora (Amsel et al., 1983). The Centers for Disease Control and Prevention recommends 
the following three regimens as treatment guidelines for BV in nonpregnant women: 500 mg of 
metronidazole taken twice daily for 7 days, intravaginal 0.75% metronidazole gel (5 mg) for 5 
days, and intravaginal 2% clindamycin cream (5 mg) for 7 days (Ward , 2002) . Treating BV with 
oral metronidazole remains the most effective treatment with the lowest recurrence rates (20% 
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compared to 34-50% for other agents). Women should be treated if they are symptomatic, 
undergoing gynaecologic surgery, or are at risk of preterm labour (Alfonsi et al., 2004). 
An UTI is diagnosed if one or more of the following symptoms are present: Painful voiding , 
nocturnal urinary inconsistinence, frequency, urgency, burning and vomiting . A urine test and in 
situ urine reactive strip test improves the chances of detecting UTls (Medina-Bombardo, 2003) . 
The Infectious Disease Society of America published guidelines recommending trimethoprim-
sulphamethoxazote in a 3-day regimen as the treatment for UTls. Fluoroquinolone are as 
effective, but more expensive, and are used in cases where women have antimicrobial resistant 
organisms or are allergic to the conventional regimens (Warren et al., 1999). The safety and 
efficiency of exogenous estrogen replacement must be confirmed with further research. The 
recommended dosage is 0.5 mg twice weekly after a loading dose, applied for 14 days (Raz, 
2001 ). 
Up to 70% of women with chlamydia infections are asymptomatic but highly contagious. The 
symptoms start 1 to 3 weeks after becoming infected and vary from vaginal discharge, 
intermenstrual or post-coital bleeding to pelvic pain . Gonorrhoea is also asymptomatic in many 
women. Symptoms include dysuria and vaginal discharge and appear 2 to 10 days after 
infection. The symptoms of syphilis are not very specific. During primary syphilis highly infectious 
sores appear anywhere on the body, usually at the site of infection. These sores resolve 
spontaneously in 2 to 6 weeks . Symptoms in secondary syphilis are highly variable, but may 
include a rash on the palms or soles. Tertiary syphilis occurs four or more years after primary 
infection. Syphilis will , if not detected, eventually cause symptoms in 40% of infected people. 
Symptoms are variable and include skin lesions and dementia. Complications may occur in the 
mucocutaneous tissue, heart, respiratory tract or nervous system (Parratt and Hay, 2003). 
Enzyme-linked immunosorbent assays (ELISA) and direct fluorescent antibody (DFA) testing are 
readily available diagnostic methods for the detection of chlamydia infections. Specificity is high 
(>95%), but sensitivity may be low (0 to 100%). Nucleic acid amplification techniques (NAA T) 
have high sensitivity (60 to 100%) and specificity (>99%) but are expensive. The method of 
choice for diagnosing gonorrhoea is culture of an endocervical or urethral swab. Not only is the 
sensitivity high (>95%), but is also an inexpensive method. Syphilis is either diagnosed by 
demonstration of T. pallidum from lesions by dark field microscopy or DFA screening , or by 
serogical testing . VDRL (venereal disease reference laboratory) or TPHA (treponema pallidum 
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haemagglutinin test) are the serogical tests used. The disadvantage of these tests is that they 
cannot differentiate between other treponemal infections (Parratt and Hay, 2003). 
The Centers for Disease Control and Prevention recommends the following treatments for STDs. 
The recommended regimens for chlamydia! infections are 1 g of azithromycin taken orally or 100 
mg of doxycycline taken orally twice a day for seven days. The following regimens are 
recommended for uncomplicated gonococcal infections: 400 mg cefixime taken in a single dose 
orally, 125 mg ceftriaxone taken intramuscularly in a single dose, 500 mg ciprofloxacin taken 
orally in a single dose, or 250 mg levofloxacin taken orally in a single dose. Benzathine penzillin 
is the recommended regimen for treating syphilis. The suggested dosage for adults is 2.4 million 
units and 50 000 units/kg up to 2.4 million units for children taken in a single dose 
intramuscularly 0Nard, 2002) . 
2. PROBIOTICS 
2. 1. Introduction 
There is a renewed interest in the use of probiotics to prevent and treat infections of the human 
gastrointestinal and urogenital tract. A probiotic is defined as a live microbial feed supplement, 
which beneficially affects the host by improving its intestinal microflora balance (Fuller, 1989). 
This definition has been revised and refined as "a preparation of, or a product containing viable, 
defined microorganisms in sufficient numbers, which alter the microflora in a compartment of the 
host and by that exert beneficial health effects in this host" (Schrezenmeir and de Vrese, 2001 ). 
Probiotics consist mainly of bacteria (especially lactic acid bacteria and bifidobacteria) and 
yeasts , especially Saccharomyces cerevisiae (Marteau and Shanahan, 2003). 
The increased resistance of pathogens to antibiotics has created the need to produce new ways 
to combat these pathogens. This has brought the focus of using probiotics not only in animal 
feed but also as a biotherapeutic agent in humans. Over the last few years , research on the 
influence of probiotics on specific diseases and medical conditions have grown substantially 
(Mombelli and Gismondo, 2000; Ouwehand et al. , 1999). Table 1 lists a few areas in which the 
beneficial effects of probiotics have been studied. 
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Table 1: Health benefits of probiotics 
Diseases and conditions beneficially effected by probiotics 
Rotavirus diarrhoea {Guandalml et al, 2000) and antibiotic-associated diarrhoea {Arvola el al., 1999) 
Treatment of urinary tract infections (de Ruiz et a/ , 1996; Reid eta/ , 1985) 
Treatment of Candida and bacterial vaginosis (Hilton el al., 1992; Mclean and Rosenstein , 2000) 
Alleviation of symptoms of lactose intolerance (Burton and Tannock, 1997) 
Reduction of serum cholestrol (Gilliland, 1990l 
Bladder and colon cancer (Akaza, 1997; Reddy, 1999l 
Food allergy (Sutas et al., 1996) 
lmmunopotentiation (Perdigon eta/., 1995) 
16 
The criteria for bacteria to be consumed as a probiotic are the following: The bacteria have to be 
of human origin and nonpathogenic. They have to be able to grow in vitro and remain viable in 
various preparations for extended periods of time. They have to be resistant to stomach acids, 
bile salts and pancreatic enzymes. They have to be able to adhere to mucosa! surfaces and 
maintain a colonized state in the host. In addition to this , they have to exert a beneficial effect by 
colonization , production of useful byproducts of bacterial metabolism, or other mechanisms 
(Marcon, 1997). 
The increase in the number of probiotic products with unreliable content and no proven clinical 
benefits has led to the development of Operating Standards in 2002. The Food and Agricultural 
Organization of the United Nation and the World Health Organization assembled guidelines to 
ensure product safety and reliability. A product can only be termed a probiotic after it has fulfilled 
the following parameters: Guidelines for the use of probiotics must be implemented. Clinical 
trials consisting of three phases must be run to prove health benefits as good as , or better than , 
standard prevention or treatment methods for a particular condition or disease. The product 
must be of high quality and have informative and precise packaging. The mechanisms of action 
in vivo must be studied and identified (Reid et al., 2005) . 
Further research is required to evaluate the safety of probiotics, especially in immunodeficient 
patients. Certain lactic acid bacteria currently used as probiotics , have been associated with 
infectious diseases in humans. Strains of Leuconostoc pseudomesenteroides have been 
recovered from patients diagnosed with UTls (Cappelli et al., 1999). Probiotic bacteria may 
transfer genes to commensal and pathogenic bacteria, thereby increasing the risk of developing 
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more antibiotic resistant bacteria. Intestinal bacteria have recently also been associated with 
inflammatory and auto-immune diseases in immunodeficient hosts. Similar problems may arise 
when probiotics are fed to immunodeficient patients (Wagner and Balish , 1998). 
2. 2. Lactic acid bacteria and probiotics 
Lactic acid bacteria (LAB) are constituted of a heterogeneous group of Gram-positive, non-
sporulating micro-aerophilic bacteria. These bacteria follow a strictly fermentative metabolism 
with lactic acid as main end product. LAB are either cocci- or rod-shaped and includes the 
following genera: Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, 
Leuconostoc, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, Oenococcus, 
Weisel/a and Melissococcus (Cai and Collins, 1994; Stackebrandt and Teuber, 1988; Stiles and 
Holzapfel , 1997). LAB are commonly used in probiotic products and foods , since they are 
desirable members of the intestinal microflora. These bacteria have GRAS (generally regarded 
as safe) status and have been used in traditionally fermented foods since the Middle Ages 
(Dunne et al. , 2001 ). 
2. 3. Natural microflora of the urogenital tract 
Lactobacillus spp. are the dominant organisms colonizing the vagina of healthy women. 
Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacil/us plantarum, Lactobacil/us 
brevis, Lactobacillus jensenii, Lactobacillus casei, Lactobacillus cellobiosus, Lactobacillus 
leichmanii, Lactobacil/us delbrueckii and Lactobacillus salivarius are associated with vaginal 
secretions (Nagy et al., 1991 ; Rogosa and Sharpe, 1960). L. acidophilus is widely accepted as 
the predominant species (Magliano et al., 1984; Nagy et al., 1991 ; Rogosa and Sharpe, 1960). 
Classical identification is not very reliable and the development of genetic identification methods 
has provided new insight on the taxonomy of vaginal lactobacilli. DNA homology studies have 
led to the revision of the taxonomy of L. acidophilus and its reclassification into six DNA 
homology groups (L. casei, Lactobacillus gasseri, Lactobacillus crispatus, Lactobacillus 
paracasei sp. nov., subsp. paracasei and subsp. tole rans, and Lactobacillus rhamnosus sp. 
nov., comb. nov.). L. gasseri and L. crispatus are frequently isolated from healthy women 
(Antonio et al., 1999). 
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Vaginal lactobacilli have been isolated from different population groups. A range of genetic 
techniques is used to identify these isolates. Giorgi et al. (1987) identified L. gasseri, L. jensenii, 
L. crispatus and L. fermentum as the species colonizing the vagina of asymptomatic women. 
During this study a genetically homologous group of heterofermentative lactobacilli that could 
represent a new species was also isolated. Dicks et al. (1994) described a new species, 
Lactobacil/us fornicalis , isolated from the posterior fornix of the human vagina . Protein 
fingerprinting suggested a close relatedness between L. fornicalis , L. gasseri and L. jensenii. 
The most frequently isolated species in this study was L. plantarum, followed by L. fermentum, 
L. crispatus and L. jensenii (Dicks et al., 1994). According to API CH Rapid strips, the 
predominant vaginal lactobacilli in 100 premenopausal women are L. jensenii (Reid et al., 1996). 
Antonio et al. (1999) isolated vaginal lactobacilli from 215 women and identified them through 
whole chromosomal DNA probes. L. crispatus, followed by L. jensenii, and a previously 
undescribed species designated L. 1086V, were the most frequently isolated. Vallor et al. 
(2001) studied the vaginal lactobacilli of 101 pregnant women and found that L. crispatus and L. 
jensenii were the predominant species. The species were identified by DNA homology. L. 
crispatus and L. gasseri were described as the dominant vaginal species from a group of 
pregnant Japanese women (Song et al., 1999). Classical methods and polymerase chain 
reaction (PCR) were used to type vaginal lactobacilli species of 200 women who were admitted 
to a gynecology clinic. The most frequently isolated lactobacilli were found to be L. gasseri, 
followed by L. delbrueckii (Alpay et al., 2002). 
Vaginal lactobacilli were also identified through 16S rRNA and 16S rDNA gene sequencing in 
four separate studies. The most commonly isolated species were L. crispatus, L. gasseri and L. 
jensenii. L. iners were also identified in two studies and L. vagina/is in another (Pavlova et al., 
2002; Tarnberg et al., 2002; Wilks et al., 2004; Zhou et al., 2004). L. crispatus, L. gasseri, L. 
iners and L. jensenii were the dominant species isolated from a group of Swedish women. The 
lactobacilli were typed by randomly amplified polymorphic DNA (RAPD) and identified by 
temporal temperature gradient gel electrophoresis, multiplex PCR and 16S rDNA sequencing 
(Vasquez et al., 2002) . L. iners and L. crispatus were the most commonly isolated vaginal 
lactobacilli when examined by PCR-denaturing gradient gel electrophoresis (DGGE) and 
sequencing of the V2-V3 region of the 16S rRNA gene (Burton et al., 2003) . 
It is evident that L. crispatus, L. gasseri and L. jensenii are the predominant vaginal lactobacilli 
(Antonio et al., 1999; Giorgi et al., 1987; Pavlova et al., 2002; Reid et al., 1996; Song et al., 
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1999; Tarnberg et al., 2002; Wilks et al., 2004; Vasquez et al., 2002; Zhou et al., 2004). L. iners 
was only recently described (Burton et al., 2003; Tarnberg et al., 2002; Vasquez et al., 2002; 
Zhou et al., 2004). This may be due to the fact that L. iners does not grow on MRS and Rogosa-
Sharpe medium, the major selective media used for the isolation of Lactobaci/lus spp. It could 
also be that the organisms have been confused with members of the L. acidophilus complex 
(Burton et al., 2003) . 
Several factors influence the natural microflora of the urogenital tract and have been 
investigated. The microflora of pre- and postmenopausal women differ, with postmenopausal 
women having a lower number of lactobacilli. The lack of estrogen in postmenopausal women, 
which stimulates the proliferation of lactobacilli, contributes to their lower lactobacilli numbers 
(Raz, 2001 ). Postmenopausal women who underwent hormone replacement therapy have the 
same vaginal lactobacilli composition as premenopausal women (Devillard et al., 2004) . 
Antibiotics have little inhibitory effect on the lactobacilli population. Metronidazole in low 
concentrations even stimulated the growth of lactobacilli (Agnew and Hillier, 1995; Simoes et al., 
2001 b) . High concentrations of metronidazole only partially inhibited the growth of lactobacilli 
(Simoes et al., 2001 b) . A randomized , double blinded, placebo-controlled crossover trial 
suggested that the spermicide, nonoxynol-9, had no adverse effects on H20rproducing 
lactobacilli. However, the use of the spermicide resulted in a loss of non-H20 r producing 
lactobacilli (Richardson et al., 1998). 
3. UROGENITAL PROBIOTICS 
3. 1. Introduction 
LAB have to comply with a list of specific characteristics to be considered a urogenital probiotic. 
They must be able to adhere to urogenital epithelial cells to colonize and persist in the urogenital 
tract. They must also be able to inhibit the growth and colonization of uropathogens in the 
urogenital tract by the production of lactic acid, hydrogen peroxide, bacteriocins and 
biosurfactants. LAB fulfilling these criteria must be tested further in in vivo studies. Clinical 
studies need to be conducted to verify if the bacteria will survive the urogenital tract. In vivo 
studies are also important to see whether probiotic cells have any adverse effects on the host. 
Urogenital probiotic characteristics will be discussed in detail below followed by results obtained 
from animal studies and clinical trials (Hoesl and Altwein, 2005; Reid , 1999). 
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3. 2. Lactic acid production 
The mild acidity of the human vagina, pH 4.5 (Paavonen, 1983; Andersch, 1986), is a key 
protective mechanism against pathogens. This low pH is microbicidal against organisms 
implicated in STD's (Hanna et al. , 1985) and UTls (Stamey and Kaufman , 1975; Skarin and 
Sylwan, 1986; Dembele et al., 1998). Bacterial vaginosis , the most common vaginal pathology 
worldwide, is also associated with an increase in vaginal pH (Eschenbach, 1993). The anaerobic 
fermentation of glycogen to lactic acid is responsible for the acidity of the vagina. During times of 
high estrogen availability glycogen is deposited into the vagina epithelial cells (Paavonen, 1983) 
and subsequently fermented by lactobacilli to lactic acid (Boskey et al., 1999, 2001) . 
3. 3. Hydrogen peroxide production 
The ability of certain lactobacilli to generate hydrogen peroxide (H20 2) is an important property 
to combat uropathogens, especially in the presence of peroxidase and a halide. Peroxidase 
utilizes H20 2 to oxidize the halide, forming the corresponding hypohalous acid or halogen, which 
has toxic properties (Boris and Barbes, 2000). L. delbruekii, L. acidophilus, L. crispatus, L. 
johnsonii and L. gasseri are dominant H20 2 producers (Strus et al., 2004). 
Only 6% of women with BV contained H20 r producing lactobacilli in their vaginas, while 96% of 
women with uninfected vaginas contained H20 r producing lactobacilli (Eschenbach et al., 1989). 
Other researchers reported similar results (Hillier et al., 1993; Klebanoff et al., 1991 ; Nagy et al., 
1991). Wilks et al. (2004) associated the low risk of BV and subsequent preterm birth in high-risk 
women with the presence of H20 r producing lactobacilli. Contradicting these results , Rosenstein 
et al. (1997) reported that pregnant women obtained BV despite the presence of H20 r producing 
lactobacilli. In a study of 182 women , BV was associated with a lack of H20 r producing 
lactobacilli , while the absence of lactobacilli did not increase the acquisition of CW or vaginal 
trichomoniasis (Hawes et al., 1996). C. albicans produces catalase that degrades the H20 2 
(Nakagawa et al., 1999). In contrast to this evidence other researchers reported the inhibition of 
C. albicans by H20 r producing Lactobacillus acidophilus (Fitzsimmons and Berry, 1994) and 
Lactobacillus strains isolated from diary products and the genital tract (Paraje et al., 2000). 
Women colonized by H20 r producing lactobacilli have decreased acquisition of HIV, N. 
gonorrhoeae and E. coli (Gupta et al., 1998; Martin et al., 1999). H20rproducing L. acidophilus 
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inhibited the growth of N. gonorrhoeae by the production of H20 2, acidification of the 
environment and production of protein inhibitors (Zheng et al., 1994). L. crispatus and L. jensenii 
inhibited N. gonorrhoeae growth in both acidic and neutral conditions. The inhibitory effect was 
lost in the presence of bovine catalase. This also suggests that H20 2 is the primary mediator of 
inhibition (Amant et al., 2002). Not only is H20 2 produced by lactobacilli inhibitory to 
uropathogens, but it has also been proposed to have an antitumor effect in the vagina (Bauer, 
2001 ; Klebanoff et al., 1991 ). 
3. 4. Bacteriocins and biosurfactants 
LAB produce inhibitory metabolites other than H202 to protect the urogenital tract against 
infection. Bacteriocins are ribosomally synthesized antimicrobial proteins or peptides that have 
shown to inhibit the growth of certain uropathogens (Tagg et al., 1976). Bacteriocins and their 
importance in the urogenital tract will be discussed in detail in the following sections. 
Biosurfactants are compounds released by microorganisms that accumulate at interfaces, most 
notably liquid-air interfaces. Certain lactobacilli produce biosurfactants that have anti-adhesive 
properties against uropathogens. Velraeds et al. ( 1996) investigated the anti-adhesive ability of 
biosurfactants produced by L. casei subsp. rhamnosus 36 and ATCC 7469, L. fermentum B54 
and L. acidophilus RC 14. The initial adhesion of E. faecalis 1131 to glass with biosurfactants 
produced by L. fermentum B54 and L. acidophilus RC14 decreased by 70% (Velraeds et al., 
1996). The anti-adhesive abilities of surlactin , produced by L. acidophilus RC14, on silicone 
rubber were also tested . Surlactin inhibited the initial adhesion of E. faecalis, E. coli and 
Staphylococcus epidermis (Velraeds et al., 1997; Velraeds et al., 1998). A 29 kDa collagen-
binding protein was characterized from the biosurfactant produced by L. fermentum RC-14. This 
protein exerts anti-adhesive activity against uropathogenic bacteria (Heinemann et al., 2000). 
The inhibition of uropathogenic biofilm growth by biosurfactants in the urine of men and women 
differ, being greater in the urine of men (Velraeds et al., 2000). 
Biosurfactants are of great interest to researchers because of their practical applications. This 
includes the use of biosurfactants to prevent biomaterial-related infections in the urinary tract. As 
earlier stated, catheter-associated UTls are the most common nosocomial infection (Hashmi et 
al., 2003) . Catheters coated with biosurfactants can reduce the adhesion of uropathogens and 
hehce reduce infection (Velraeds et al., 1997). Biosurfactants can also be applied to prevent 
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biofilm formation on ureteral stents. Ureteral stents are implanted to improve kidney drainage. 
The attachment of uropathogens leads to infection and this can lead to serious kidney damage. 
Research showed that coating the stents with the protein (29 kDa) isolated from L. fermentum 
RC-14 reduced attachment of E. coli 67 and Ent. faecalis 1131 in vitro . However, the protein had 
no effect when the stents were coated with urine before the challenge (Cadieux et al. , 2003; 
Heinemann et al., 2000). 
3. 5. Adhesion of lactic acid bacteria to the urogenital epithelial cells 
Adhesion of LAB to uroepithelial and vaginal epithelial cells (VEC) is not only important for the 
colonization of the vagina, but also forms a protective barrier against pathogenic bacteria (Chan 
et al., 1985). LAB differ in their ability to adhere to epithelial cells . Lactobacilli isolated from the 
vagina (Ocana and Nader-Macias, 2001 ; Wood et al., 1985) and the urinary tract (Reid et al., 
1987; Chan et al., 1984) have higher adherence than lactobacilli isolated from other sources. 
The cell surface structure of LAB plays an important role in their adhesion abilities. Three 
vaginal lactobacilli that adhere strongly to VECs surfaces were studied. In the case of L. 
acidophilus and L. gasseri, adherence involve proteins and a carbohydrate, while in L. jensenii 
adherence depends exclusively on carbohydrates (Boris et al., 1998). An extracellular, 
proteinaceous adhesin and a trypsin-insensitive cell wall adhesin were identified from lactobacilli 
species that adhere strongly to uroepithelial cells (Reid et al., 1993). Lipoteichoic acid in the cell 
wall has also been suggested to be responsible for the adherence of Lactobacillus cells to 
uroepithelial cells (Chan et al., 1985). L. fermentum RC-14, L. rhamnosus GR-1 and 36, and L. 
casei Shirota produce biosurfactants, which contain proteins that bind to both collagen types Ill 
and IV. These proteins may play an important role in the adhesion of the bacteria since collagen 
is a major component of the dermis (Howard et al., 2000). 
Fimbriation increases the adhesion of lactobacilli to VECs in vitro (McGroaty, 1994). Lactobacilli 
were grouped based on their ability to hemagglutinate red blood cells (RBCs) (Andreu et al., 
1995). Strains from group II (hemagglutinated sheep and human RBCs) and group Ill 
(hemagglutinated all the RBCs studied) adhered in large numbers to VECs. A direct correlation 
was found between the strains' adhesion ability and their hemagglutination patterns (Andreu et 
al., 1995). 
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Lactobacilli inhibit uropathogens from adhering by competitive exclusion, auto-aggregation , and 
co-aggregation with uropathogens. Pre-incubation of uroepithelial cells with Lactobacillus strains 
completely or partially inhibited the adherence of several uropathogens (Chan et al., 1984; Chan 
et al., 1985; Reid et al., 1987). Reid et al. (1988) was first to observe co-aggregation between 
lactobacilli and uropathogens. Surface proteins of lactobacilli have been identified that co-
aggregate and aggregate with pathogens. An example of these proteins is the 19.9 kDa 
prepeptide produced by L. coryniformis DSM 20001T. This prepeptide is encoded by the cpf 
gene and is responsible for co-aggregation and aggregation with the human pathogens E. coli 
K88, Campylobacter coli, and C. jejuni (Schachtsiek et al., 2004). An aggregation promoting 
factor, a 2 kDa hydrophilic peptide, was also isolated from vaginal L. gasseri 2459 (Boris et al., 
1997). Lactobacilli from hemagluttination group Ill showed a greater capacity to block 
uropathogens adherence than lactobacilli from hemagglutination groups II and I (Osset et al., 
2001 ). The ability of lactobacilli to closely interact with uropathogens constitutes an important 
host defense mechanism against infection. 
3. 6. In vivo probiotic studies of the urogenital tract 
Reid and co-workers studied the urogenital properties of L. rhamnosus GR-1 and GG, and L. 
fermentum RC-14 extensively. The three strains were selected for clinical studies based on their 
adherence to epithelial cells (Reid, 1999), although L. rhamnosus GG was not able to colonize 
the human vagina (Colodner et al., 2003; Gardiner et al. , 2002) . Furthermore, they have the 
ability to inhibit uropathogens (Reid, 1999). L. rhamnosus GR-1 and L. fermentum RC-14 have 
been detected in the vagina following oral intake. In the same study six cases of asymptomatic 
or intermediate bacterial vaginosis were resolved within one week (Reid et al., 2001 a). The 
efficacy of orally administered lactobacilli to restore and maintain a healthy vagina was further 
investigated in a trial consisting of 42 women. Women received encapsulated L. rhamnosus GR-
1 plus L. fermentum RC-14 or L. rhamnosus GG orally. A healthy flora was reported in 90% of 
women treated with L. rhamnosus GR-1 and L. fermentum RC-14. Symptomatic BV was 
resolved or converted to asymptomatic BV in 7 of 11 people. Treatment with L. rhamnosus GG 
had no effect (Reid et al., 2001b). The safety of the daily intake of L. rhamnosus GR-1 and L. 
fermentum RC-14 was tested in a randomized, placebo-controlled trial consisting of 64 women. 
The women showed no adverse effects after taking the capsules for 60 days. Asymptomatic BV 
microflora returned to normal lactobacilli microflora in 37% of the women who received the 
lac'tobacilli treatment compared to the 13% of the placebo group (Reid et al. , 2003) . 
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L. fermentum CRL 1058 was inoculated intraurethrally into 2 month-old female mice. The mice 
were then challenged by the same method with E. coli and K. pneumoniae. A double dose of 
lactobacilli (107 CFU per dose) were adequate to protect the mice from E. coli. The pathogen 
disappeared completely by the third day. L. fermentum was ineffective against K. pneumoniae 
(Nader de Macias et al., 1996). The effect of antibiotics and estrogen were tested on the 
colonization and efficiency of L. fermentum CRL 1058. L. fermentum CRL 1058 was shown to be 
effective with low doses of orally applied ampillicin (de Ruiz et al., 1996) and one dose of beta-
estradiol (de Ruiz et al., 2001 ). Lastly, histological and ultrastructural techniques were used to 
evaluate the effect of L. fermentum CRL 1058 on the organs of the urinary tract. L. fermentum 
CRL 1058 had no adverse effect on the urinary tract organs ensuring that the lactobacil/us is safe 
to be used as a probiotic for UTls (de Ruiz et al., 2003). 
L. acidophilus is present in a wide range of dairy products and the L. acidophilus NCFM™ strain 
is a known commercial probiotic for the intestine. Since L. acidophilus is widely consumed , 
clinical studies were undertaken to see if the lactobacilli had a beneficial effect in the urogenital 
tract (Reid , 1999; Sieber and Dietz; 1998). L. acidophilus inhibited the growth of C. albicans. 
Vaginal implantations of nonfermented L. acidophilus milk products for preventing recurrence of 
vaginitis after Nystatin treatment were studied on 30 women . The ingestion of L. acidophilus 
containing milk products was shown to decrease the number of Candida infections in two 
separate studies (Collins and Hardt, 1980; Hilton et al., 1992). 
In another study, 28 women with recurrent non-specific vaginitis were treated with a vaccine 
containing inactive strains of L. acidophilus. The vaccine clinically cured or at least markedly 
improved the vaginal microflora of 85.6% of the cases (Muller and Salzer, 1983). Lyophilized , 
H20 r producing L. acidophilus was also used to treat 60 women with BV. After treatment, 16 of 
the 28 women who were treated with lactobacilli had normal vaginal smear results, compared to 
none of the 29 women in the placebo group (Hallen et al., 1992). Ingestion of yogurt containing 
live L. acidophilus was compared with pasteurized milk. The study concluded that the ingestion 
of yogurt enriched with L. acidophilus might reduce episodes of BV (Shalev et al., 1996). The 
effect of L. acidophilus in combination with estriol was also tested in a multicentric, randomized , 
placebo-controlled clinical trial consisting of 32 women experiencing BV. The treatment not only 
increased the cure rate but the lactobacilli were also able to recolonise the vagina (Parent et al., 
1996). 
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The in vitro characteristics of L acidophilus NCFM™ were investigated by Reid (2000) to 
examine its suitability as an urogenital probiotic. L. acidophilus NCFM™ is able to adhere to 
urogenital cells and produce biosurfactants that inhibits uropathogenic enterococci adhesion. L. 
acidophilus NCFM™ probiotic properties are not as high as those of L. rhamnosus GR-1 and L. 
fermentum RC-14. Hence Reid (2000) suggested that although L. acidophilus applied directly to 
the vagina may be feasible , it would not be the optimal choice for a urogenital probiotic (Reid, 
2000) . 
4. BACTERIOCINS 
4. 1. Introduction 
LAB are well known for their production of ribosomally synthesized antimicrobial proteins or 
peptides, collectively known as bacteriocins. Bacteriocins exhibit antimicrobial properties against 
other bacterial species that are usually closely related to the producer strain . LAB bacteriocins 
are, in general , small cationic proteins with high isoelectric points and amphiphilic characteristics 
(Tagg et al., 1976). LAB that produce bacteriocins have been used for extending the shelf life of 
foods . Nisin is the only bacteriocin licensed as a food preservative and has been produced 
commercially since 1953 (Parente and Ricciardi , 1999). The application of bacteriocins to treat 
and prevent infectious diseases has received a lot of attention over the last few years and the 
field of research is still growing. 
4. 2. Classification of bacteriocins 
Bacteriocins produced by Gram-positive bacteria are divided into two main groups: Group I 
consists of modified bacteriocins (the !antibiotics), and group II of the unmodified peptide 
bacteriocins (nonlantibiotics) (Nissen-Meyer and Nes, 1997). Klaenhammer classified lactic acid 
bacterial bacteriocins further into four distinct classes based on their biochemical and genetic 
characteristics, structures and mechanisms of action . Class I consists out of !antibiotics, small 
membrane-active peptides (< 5 kDa) containing the unusual amino acids lanthionine, 13-methyl 
lanthionine and dehydrated residues . Nisin , lacticin 481 , carnocin U149 and lactocin S are a few 
!antibiotics (Klaenhammer et al., 1993). Class II is the small heat-stable, non-lanthionine 
containing , nonmodified peptides (< 1 O kDa). The group is further divided into three subgroups, 
namely class Ila ; the antilisterial bacteriocins with the YGNG motif; class llb the two-peptide 
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bacteriocins ; and class lie the other small heat stable nonlantibiotics which do not fall into the 
first two groups (Eijsink et al., 2002) . Previously, sec-dependent secreted bacteriocins were 
classified as class lie bacteriocins. Pediocin PA-1 , lactococcin A, leucocin A, sakacin A, curvacin 
A and lactacin F are all class II bacteriocins. Class Ill is the large heat-labile proteins (< 30 kDa) 
and is characterized by helveticin J, helveticin V-1829, acidophilucin A and lactacins A and B. 
Class IV consists out of complex bacteriocins composed of a protein plus one or more chemical 
moieties required for activity. Plantaricin S, leuconocin S, lactocin 27 and pediocin SJ-1 are 
examples of class IV bacteriocins (Klaenhammer, 1993). 
4.3. Class Ila bacteriocins 
Class Ila bacteriocins are characterized on their antilisterial activity and the presence of the 
YGNGX2CX4CXV motif (X represents any amino acid) in their N-termini. The two cysteines form 
a disulfide bridge and the motif has been suggested to be part of a recognition sequence. Class 
Ila bacteriocins are produced by a variety of lactic acid bacteria, including Lactobaci//us, 
Enterococcus, Pediococcus, Carnobacterium, Leuconostoc and Weisel/a. The class Ila 
bacteriocins characterized so far contains between 37 and 48 residues . Other characteristics 
shared among these proteins are their net positive charge with iso-electric points varying from 
8.3 to 10, their high content of non-polar amino acid residues and small amino acids (Eijsink et 
al., 2002; Ennahar et al., 2000). 
4. 4. Biosynthesis of bacteriocins and the genes involved 
Bacteriocins of LAB are produced as pre-peptides with short N-terminal leader sequences 
cleaved during maturation. Cleavage of the leader peptides is conducted by specific peptidases, 
either praline or glycine, or by a proteolytic domain of the dedicated ABC transporter. The leader 
peptides contain highly conserved sequences that are recognized by the peptidases or 
proteolytic domain of the ABC transporters (Klaenhammer, 1993; Nes et al., 1996). 
The genes required for the production of non-modified bacteriocins are in close proximity and 
are as follows: ( 1) the structural gene (two structural genes for the two-peptide bacteriocins) 
encoding for the pre-peptide, (2) an immunity gene that protects the producer against its own 
bacteriocin , (3) a gene encoding a membrane-associated ABC transporter that transfers the 
' 
bacteriocin across the membrane, and (4) a gene encoding an accessory protein also needed 
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for secretion of the bacteriocin (Nes et al., 1996). The gene structure of sec-dependent 
bacteriocins is different and will be discussed later. Similarities exists between genes involved in 
the production of modified and unmodified bacteriocins. This is because both modified and 
unmodified bacteriocins are synthesized from prepeptides with characteristic N-terminal leader 
peptides. The genes involved in the production of !antibiotics are as follows: (1) the structural 
gene encoding the !antibiotic pre-peptide, (2) one or more immunity proteins, (3) a serine 
protease that presumably functions to cleave off the leader sequence, (4) one or two proteins 
catalyzing dehydration and lanthionine ring formation, and (5) the two-component regulatory 
proteins that transmit an extracellular signal and thereby induce bacteriocin expression (Jack 
and Sahl, 1995). 
4.5. Mode of action 
The common mode of action is dissipitation of the proton motive force (PMF) . Bruno and 
Montville demonstrated this by investigating the influence of bacteriocins from the four major 
classes, pediocin PA-1 , leuconocin S, lactacin F, and nisin , on the PMF of a sensitive cell . They 
mediated the total or major dissipation of the PMF in sensitive cells in a concentration-
dependent manner (Bruno and Montville, 1993). PMF plays a fundamental role in bacterial 
energy metabolism. PMF dissipation leads to low intracellular levels of ATP, the inability to 
conduct active transport of nutrients, and the inability to maintain sufficient concentrations of co-
factors . This ultimately leads to growth inhibition and cell death (Konisky, 1982). Treatment of 
sensitive cells with !antibiotics leads to ATP leakage (Moll et al., 1996), compared to no leakage 
when sensitive cells are treated with class II bacteriocins. This could be due to the fact that the 
pores formed with class II bacteriocins are smaller in size. ATP depletion is suggested to be the 
result of the cell 's attempt to regenerate the decreased PMF (Ennahar et al., 2000). 
The secondary structure of bacteriocins plays an important role in the pore formation in sensitive 
cells . Barrel-stave poration complexes have been proposed for a number of bacteriocins in 
which a-helices or ~-sheets form two faces , the one hydrophobic and the other one hydrophilic. 
Lateral oligomerization of peptide monomers occurs in the membrane with the hydrophobic part 
facing the membrane and the hydrophilic part forming the pore (Nissen-Meyer and Nes, 1997). 
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4.6. Sec-dependent bacteriocins 
The majority of bacteriocins produced by lactic acid bacteria contain a double-glycine motif in 
their N-terminal leader sequence that serves as recognition signal for protein processing and 
secretion. Dedicated ATP-binding cassette (ABC) transporters and their accessory proteins 
remove the Gly-Gly double motif leader sequence and translocate the bacteriocins across the 
cytoplasmic membrane (Haverstein et al., 1995). There is, however, a small group of 
bacteriocins that does not contain the double-glycine motif in their N-terminal. These 
bacteriocins are sec-dependent and are secreted through the general secretory pathway (Cintas 
et al., 1997). 
Sec-dependent signal peptides are divided into three distinct domains, namely the N, C, and H 
regions according to von Heijne's rules for signal peptides. The first 6 to 8 amino acids contain at 
least one lysine and makes up the N region. The H region is the middle part of the signal peptide 
and has a strong hydrophobicity. The C region contains the cleavage site, which consists of a 
neutral amino acid flanked by small side chains at position -3 and -1 (von Heijne and 
Abrahmsen , 1989). 
Divergicin A (Worobo et al., 1995), acidocin B (Leer et al., 1995), enterocin P (Cintas et al., 
1997), bacteriocin 31 (Tomita et al., 1996), lactococcin 972 (Martinez et al., 1999) and 
enterolysin A (Nilsen et al., 2003) are sec-dependent bacteriocins. The class Ila sec-dependent 
bacteriocins enterocin P and bacteriocin 31 , produced by Enterococcus faecium and 
Enterococcus faecalis, respectively, have 44 and 43 amino acids (Cintas et al., 1997; Tomita et 
al., 1996). Divergicin A and acidocin B, produced by Carnobacterium divergens LV13 and 
Lactobacil/us acidophilus M46, are heat stable hydrophobic bacteriocins and does not contain 
the conserved YGNG motif (Leer et al., 1995; Worobo et al., 1995). Lactococus lactis subsp. 
lactis IPLA 972 produces lactococcin 972, which is composed of two copies of a single 7.5 kDa 
peptide. Unlike other two-peptide class lib bacteriocins , lactococcin 972 has only one structural 
gene. Another interesting observation is that the monomer is hydrophilic in its active form , 
indicating that the membrane is not its primary target (Martinez et al., 1999). Enterolysin A 
produced by Enterococcus faecalis LMG 2333 is a large heat-labile class Ill bacteriocin. The 
mature bacteriocin consists of 316 amino acids and has a weight of 34. 5 kDa (Nilsen et al., 
2003). It's clear that sec-dependent bacteriocins are present in all the different classes of 
. 
bacteriocins and that they have diverse characteristics. 
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The gene encoding enterocin P (entP) was cloned in Pichia pastoris. The yeast successfully 
produced the protein in high quantities with high antimicrobial activity. P. pastoris X-33t1 grown 
in BMMY medium increased enterocin P protein production by 3. 7-fold and 16-fold greater 
antimicrobial activity (Gutierrez et al., 2005c). Previous heterologous bacteriocin expression of 
pediocin PA-1 (Beaulieu et al., 2005; Schoeman et al., 1999) and plantaricin 423 (van Reenen et 
al., 2002) in P. pastoris and Saccharomyces cerevisiae were less successful. In the latter three 
studies the supernatants had either no antimicrobial activity or low activity after the supernatant 
was concentrated. EntP was also successfully cloned into E. coli (Gutierrez et al., 2005b) and 
Methylobacterium extorquens (Gutierrez et al., 2005a) and the active enterocin P detected in the 
supernatants. 
4. 7 Enterococcus spp. and their bacteriocins 
Enterococcus spp. were previously classified as Streptococcus sensu Jato. DNA:DNA and 
DNA:rRNA hybridization studies showed that Streptococcus faecalis and Streptococcus faecium 
are phylogenetically distinct from other streptococci. They were reclassified as Enterococcus 
(Schleifer and Kilpper-Balz, 1984; 1987). Since then 28 species have been added to the genus 
Enterococcus based on phylogenetic evidence strengthened by 16S rRNA DNA sequencing 
and/or DNA DNA hybridization studies (Moreno et al., 2005). 
Enterococci are widely distributed in the environment and are present in foods, the 
gastrointestinal tract of humans and animals, water and soil (Franz et al., 1999; Moreno et al., 
2005) . Enterococci are used in the fermentation of certain dairy products (Giraffa, 2003) , meat 
products (Hugas et al., 2003) , and olives (Franz et al., 1996), and in probiotic preparations 
(Benyacoub et al., 2003; Pollmann et al., 2005) . Enterococci enhance the flavour and taste of 
cheese during ripening through proteolysis, lipolysis and citrate breakdown (Litopoulou-
Tzanetaki and Tzanetakis, 1992; Manolopoulou et al., 2003) and serves as a natural 
preservative in food fermentations (Hugas et al., 2003; Laukova and Czikkova, 2001 ; Laukova et 
al., 1999). 
E. faecalis and E. faecium produce bacteriocins generally referred to as enterocins. The different 
bacteriocins produced by enterococci are listed in Table 2. Enterocins, as most other 
bacteriocins , target the cytoplasmic membrane of sensitive cells and dissipates the 
transmembrane potential and/or pH gradient, leading to cell inhibition and death (Moreno et al., 
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2005). Production of enterocins and the inhibitory spectrum of 122 enterococci were tested by 
de Vuyst et al. (2002) . The inhibitory spectra of the enterocins varied considerably, inhibiting 
closely related enterococci , other LAB, food spoilage and pathogenic bacteria. Furthermore no 
correlation could be found between the origin of the strain , the type of inhibitory spectrum and/or 
the presence of enterocin genes. 
TABLE 2: Bacteriocins produced by Enterococcus spp. 
Bacteriocins Producer strain Isolated from Size Reference 
(kDa) 
Class I: 
Cyl LL and Cyl8 E. faecalis OS 16 Gilmore et al. 
(1994) 
Class Ila: 
Enterocin A E. faecium P21 , Dry-fermented 4.8 Herranz et al. 
E. faecium WHE 81 saugages; cheese (2001 ), 
Ennahar et al. 
(2001) 
Enterocin P E. faecium P13 Dry-fermented 4.5 Cintas et al. 
saugage (1997) 
Bacteriocin 31 E. faecalis Yl717 Clinical isolate 5.0 Tomita et al. 
(1996) 
Mundticin E. mundtii AT06, Vegetables and 4.3 Bennik et al. 
E. mundtii KS grass silage (1998), 
Kawamato et 
al. (2002) 
Enterocin CRL35 E. faecium CRL35 Cheese 3.5 Wachsman et 
al. (2003) 
Enterocin SE-K4 E. faeca!is SE-K4 Grass silage 4.9 Eguchi et al. 
(2001) 
Bacteriocin RC714 E. faecium RC714 Human fecal sample 4.9 Del Campo et 
al. (2001) 
Class lie: 
Enterocin AS-48 E. faecalis subsp. Intestinal tract of 7.1 Galvez et al. 
liquefaciens S-48 porcine (1986), 
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Enterocin B 
Enterocin 1071A 
and1071B 
Enterocin EJ97 
Enterocin RJ-11 
Enterocins L50A, 
L50B and Q 
Class Ill: 
Enterolysin A 
E. faecium P21 ; 
E. faecium WHE 81 
E. faecalis BFE 1071 
E. faecalis EJ97 
E. faecalis RJ-11 
E. faecium L50 
E. faecalis LMG 2333 
Dry-fermented 
saugages; cheese 
Feces of porcine 
Municipal water 
Rice bran 
5.5 
4.3 
and 
3.9 
5.3 
5.0 
Spanish dry- 5.1, 
fermented sausages 5.2 
31 
Samyn et al. 
(1994) 
Herranz et al. 
(2001 ), 
Ennahar et al. 
(2001) 
Balla et al. 
(2000) 
Sanchez-
Hidalgo et al. 
(2003) 
Yamamoto et 
al. (2003) 
Cintas et al. 
(1998) , 
and Cintas et al. 
3.9 (2000) 
LMG panel 34,5 Nilsen et al. 
(2003) 
The presence of enterococci in food products and probiotics presents a potential health risk. 
This is a result of the emergence of enterococci that is resistant to glycopeptides and antibiotics, 
the production of biogenic amines, and the finding of virulence traits in both clinical and food 
borne isolates. The safety of enterococci is also in question because of the role they play in 
nosocomial infections including bacteraemia, endocarditis, urinary tract, neonatal , central 
nervous system (CNS) , intraabdominal, and pelvic infections (Franz et al., 1999; Moreno et al., 
2005) . 
4. 8. Bacteriocins and the urogenital tract 
Ba.cteriocins and bacteriocin-like inhibitory substances active against uropathogens have been 
identified and described. L. acidophilus 160 produces a bacteriocin active against 9 different 
Stellenbosch University  https://scholar.sun.ac.za
32 
isolates of G. vagina/is (Aroutcheva et al., 2001 ). Not all bacteriocins produced are active 
against G. vagina/is. Aroutcheva (2001) reported that about 80% of vaginal lactobacilli tested 
produced bacteriocins active against G. vagina/is . In another study, 8 out of 36 strains of G. 
vagina/is tested were susceptible to a bacteriocin produced by L. acidophilus (Simoes et al., 
2001 a). A bacteriocin-like inhibitory substance was isolated from a vaginal strain of Lactobacillus 
salivarius subsp. sa/ivarius CRL 1328 with activity against E. faecalis, E. faecium , and N. 
gonorrhoeae (Ocana et al., 1999). Mutacins A, B, I, J and T produced by Streptococcus mutans, 
nisins A and Z produced by Lactococcus /actis subsp. lactis , and epidermin produced by S. 
epidermis, inhibited two antibiotic-resistant strains of N. gonorrhoeae (Morency et al. 2001 ). 
Enterocin CRL35 (Wachsman et al., 2003) and Enterocin ST4V (Todorov et al., 2004), produced 
by E. faecium CRL35 and E. mundtii ST4V, even inhibited replication of the HSV. 
Bacteriocins produced by bacteria other than LAB have activity against uropathogens (Barberis 
et al., 1997; Sharma et al., 2002; Smith and Stiles, 1980). Strains of Streptococcus faeca/is 
produce inhibitors resembling enterococcal bacteriocins that inhibit the growth of G. vagina/is 
and N. gonorrhoeae (Smith and Stiles, 1980). Eubacterium limosum produces more than one 
low molecular weight amino compound that inhibited the growth of N. gonorrhoeae (Morin et al., 
1984). Several Pseudomonas aeruginosa strains produce bacteriocins called pyocins. Pyocins 
whose sensitivity is subject to environmental changes inhibits the growth of N. gonorrhoeae by 
interfering with its energy metabolism (Barberis et al., 1997; Morse et al., 1980; Stein et al., 
1980; Stein et al., 1983). Photorhabdus luminescens is an insect pathogenic bacterium that 
produces a bacteriocin , luminescens, active against uropathogenic E. coli (Sharma et al., 2002) . 
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SHORT NOTE 
SCREENING OF LACTIC ACID BACTERIA FOR ANTIMICROBIAL PEPTIDES 
INHIBITORY TO ISOLATES OF ENTEROCOCCUS FAECAL/SAND CANDIDA ALB/CANS 
FROM PATIENTS DIAGNOSED WITH VAGINOSIS 
M. de Kwaadsteniet, C.A. van Reenen and L.M .T. Dicks 
Department of Microbiology, Stellenbosch University, 7600 Stellenbosch, South Africa 
A total of 125 lactic acid bacteria (LAB) were screened for antimicrobial activity against five 
isolates of Enterococcus faecalis and a Candida albicans strain , respectively, isolated from 
patients diagnosed with vaginosis. Three LAB strains, viz. Lactobacillus plantarum 423 
isolated from sorghum beer, Enterococcus mundtii ST15 from soy flour, and a catalase-
negative coccus (strain TB) isolated from the faeces of HIV-infected children , inhibited the 
growth of the Enterococcus faecalis and Candida albicans isolates on plates . None of the 
three strains produced hydrogen peroxide. The antimicrobial peptide produced by strain 423 
is similar to peptide TV35b, an anti-Candida peptide produced by Lactobaci/lus pentosus 
TV35b described in one of our previous papers. The bacteriocin-like peptides produced by 
strains ST15 and TB are 3.94 and 5.07 kb in size, respectively. 
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Lactic acid bacteria (LAB), including Enterococcus spp., are natural inhabitants of the 
urogenital tract (Song et al. , 1999). Enterococcus faecalis has, however, been associated 
with urinary infections (Preston et al., 1992; Reid and Seidenfeld, 1997), especially in HIV-
infected patients (Schonwald et al., 1999). The species has also been linked to secondary 
bacteraemia (Lerma et al., 2003). Untreated infections may lead to pyelonephritis (kidney 
infection) , premature delivery, infertility, fetal mortality, impaired renal function , pelvic 
inflammatory diseases, cervical cancer and even increased transmission of HIV (Foxman, 
2003; Jung et al. , 2004; Martin et al., 1999; Parratt and Hay, 2003; Rhoton-Vlasak, 2000 ; 
Romero et al., 2004) . Candida albicans is associated with 80-90% of reported cases of 
candidal vaginosis (Sobel, 1993) and affects more than 1 billion women worldwide annually 
(Reid and Bruce, 2003). Approximately half of those infected experience recurrent infections 
(Ferrer, 2000) . 
Many of the uropathogens form biofilms , rendering them inaccessible to antibiotic treatment 
(Greiner et al., 2005; Mukherjee et al. , 2005; Swidsinski et al., 2005; Tendolkar et al. , 2005). 
Furthermore, extensive antibiotic treatment decreases the natural population of lactic acid 
bacteria in the vagina, which favours colonization of pathogens . This may lead to an increase 
in the acquisition of sexually transmitted diseases (Martin et al., 1999; van der Wijgert et al., 
2000; Mbizvo et al., 2001) , bacterial vaginosis (Eschenbach et al., 1989; Klebanoff et al., 
1991 ; Nagy et al., 1991) and urinary tract infections (Gupta et al., 1998). 
Vaginal infections may be treated by colonizing the urogenital tract with LAB (Collins and 
Hardt, 1980; Hilton et al., 1992; Hoesl and Altwein , 2005; Nader de Macias et al., 1996; Reid 
et al., 2001 a,b; 2003). If carefully selected and correctly administered , these bacteria adhere 
to the mucus or epithelial cells and form a physical barrier against invasive pathogens (Song 
et al., 1999) . Many of these probiotic strains produce hydrogen peroxide and antimicrobial 
peptides (bacteriocins) active against pathogens (Hoesl and Altwein , 2005). 
The purpose of this study was to screen LAB from plant , animal and human origin for the 
production of antimicrobial peptides active against uropathogenic strains of E. faecalis and C. 
albicans. 
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MATERIALS AND METHODS 
Strains and growth conditions. Lactic acid bacteria were cultured in Mann Ragasa 
Sharpe (MRS) broth (Biolab, Biolab Diagnostics, Midrand, South Africa) . Strains of E. 
faecalis were propagated in Brain Heart Infusion (BHI) broth (Biolab) and C. albicans in YPD 
broth (yeast extract, 10 g r1; peptone, 20 g 1"1; glucose, 20 g 1"1) . Incubation of all strains was 
at 37°C. Escherichia coli Bluescript and DH5a. were cultured in Luria Bertani (LB) broth 
(Biolab) , at 37°C with aeration . Bacteria were stored at -80°C in the presence of 40% (v/v) 
glycerol and C. albicans in the presence of 30% (v/v) glycerol. 
Isolation of E. faecalis and C. albicans and identification to species level. S wabs 
collected from the vagina of patients diagnosed with vaginosis were suspended in BHI broth 
(Biolab) and YPD broth, respectively; incubated at 37°C for 24 h, streaked onto 
corresponding agar media and incubated for 24 - 48 h. Individual colonies were selected 
from plates displaying between 50 and 100 colonies and streaked to purity. 
Bacteria isolated from BHI agar plates were Gram-stained and tested for catalase activity. 
Gram-positive, catalase-negative cocci were identified to genus level by phenotypic 
characteristics (Holt, 1994) and to species level by 168 rDNA sequencing . Total DNA was 
isolated using the High Pure PCR Preparation Kit (Roche Diagnostics, Indianapolis, USA). 
Amplification was by PCR using the 16S rDNA primers and conditions described by Felske et 
al. (1997) . Amplified fragments were cloned into pGEM®-T Easy Vector Systems (Promega , 
Madison, USA). Constructs were transformed into E. coli DH5a., according to the method of 
Ausubel (1994 ). Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen®, 
Valencia , California , USA) and sequenced with an ABI Prism ™377 DNA Sequencer (PE 
Biosystems SA, Pty, Ltd). All ligations and transformations were performed according to 
standard procedures (Ausubel , 1994) . Homology with sequences in GenBank was 
determined by using the BLAST program (Altschul et al., 1997). 
Yeast-like colonies collected from YPD plates were examined morphologically and identified 
to species level by using the API 20 C AUX system (Biomerieux, France) . 
Screening of LAB for antimicrobial activity. A total of 125 LAB, isolated from plants, 
animals and humans (from our own culture collection) were screened for antimicrobial 
activity against five E. faecalis isolates by using the agar-spot test and the well-diffusion 
methods (Schillinger and Lucke, 1989 ; Tagg and McGiven, 1971) . The same strains were 
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screened for antimicrobial activity against the C. albicans isolate by spotting cell-free 
supernatants onto YPD-agar plates seeded with C. albicans (106 cfu/ml) . Activity was 
expressed in arbitrary units (AU) per ml. One AU is defined as the reciprocal of the highest 
serial two-fold dilution showing a clear zone of growth inhibition (van Reenen et al. , 1998). 
H20 2 production was determined by growing the bacteria on MRS agar plates containing 
0.25 mg/ml 3',3'-5',5'-tetramethylbenzidine (TMB) (Sigma-Aldrich , St. Louis , USA) and 0.01 
mg/ml horseradish peroxidase (Roche Diagnostics). If H202 is produced , peroxidase releases 
oxygen that produces blue colonies in the presence of oxygen (Eschenbach et al., 1989; 
Song et al., 1999) . 
Isolation of antimicrobial proteins. LAB with antimicrobial activity against E. faecalis and 
C. albicans were cultured in 500 ml MRS broth at 37°C for 24 h. Cells were harvested 
(10 000 x g, 10 min , 4°C) and proteins precipitated from cell-free supernatants with 80% 
saturated ammonium sulphate (Sambrook et al., 1989). Precipitates were collected by 
centrifugation (9 000 x g, 1h, 4°C) and the pellets suspended in 10 ml ammonium acetate 
(pH 6.5) . The concentrated proteins were dialysed against 4 I sterile distilled water using a 
Spectra-Par membrane with a 1000 Da cut-off (Spectrum Inc., CA, USA). 
Cell aggregation. Cell aggregation (clumping) was studied by using a modified method of 
Lee et al. (2005) . Lactobacillus plantarum 423, E. mundtii ST15 and strain T8 were grown in 
MRS broth (Biolab) for 24 h, washed twice (10 min, 10 000 x g, 4°C) with sterile physiological 
water, and resuspended in Keratinocyte-SFM medium (GIBCO, lnvitrogen Corporation , 
Auckland , N.Z) . After 4 h at 37°C, the cells were examined for aggregation under a light 
microscope (600 x magnification) . Co-aggregation between these three strains and E. 
faecalis and C. albicans, respectively , was studied using the same method. Once added 
together, the cells were incubated for 4 h at 37°C on a rotating wheel. The cells were Gram-
stained and examined for aggregation as described before. 
RESULTS 
Identification of E. faecalis and C. albicans. Five colonies selected from BHI plates were 
Gram-positive cocci , catalase negative and homofermentative (no C02 production from the 
fermentation of glucose). The 16S rDNA of the five isolates shared 84% homology with the 
16S rDNA sequence of E. faecalis strain 013 listed in Gen Bank (accession number 
gil78499506 1gblDQ23964.·l I). A yeast colony was selected from YPD plates and classified as 
C. albicans according to reactions obtained by API 20 C AUX. 
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LAB strains with antimicrobial activity against E. faecalis and C. albicans. From a total 
of 125 lactic acid bacteria, only three strains, viz. L. plantarum 423, E. mundtii ST15 and a 
catalase-negative coccus (strain T8) inhibited the growth of the five E. faecalis strains 
isolated from patients diagnosed with vaginosis (Table 1 ). Antimicrobial activity levels 
recorded in cell-free supernatants of L. plantarum 423 and E. mundtii ST15 were low (400 
and 1 600 AU mr1, respectively) , but increased to 51 200 and 102 400 AU/ml, respectively , 
after ammonium sulphate precipitation . Low antimicrobial activity was recorded for strain T8 
(400 AU mr1 in cell-free supernatant and 1 600 AU mr1 after ammonium sulphate 
precipitation) . 
Cell-free supernatants of L. plantarum 423 , E. mundtii ST15 and strain T8 caused only slight 
growth inhibition of C. albicans on plates. However, the morphology of C. a/bicans was 
clearly impaired when treated with the cell-free supernatants. The cells treated with the cell-
free supernatant grew in small clumps and not as evenly as the untreated cells . 
L. plantarum 423 decreased the medium pH from 6.4 to 3.5 within 24 h of growth . E. 
mundtii ST15 and strain T8, on the other hand, produced less acid and lowered the pH to 
4.3. None of the three strains tested produced H20 2 when grown on modified MRS agar. 
Cell aggregation. The cells of L. plantarum 423, E. mundtii ST15 and strain T8 were 
arranged separately and did not form aggregates. No cell aggregation was detected between 
the E. faecalis isolates and L. plantarum 423 , E. mundtii ST15 or strain T8, respectively (not 
shown). However, E. mundtii ST15 and strain T8 aggregated with cells of C. albicans (Fig. 
1). No aggregation was recorded between L. plantarum 423 and C. albicans (Fig . 1). 
DISCUSSION 
Strains of E. faecalis and C. albicans isolated from patients diagnosed with vaginosis were 
positively identified by 168 rDNA sequencing and API 20 C AUX fermentation reactions, 
respectively. The bacteriocin-like peptide produced by E. faecium ST15 was the most 
effective , followed by plantaricin 423 and the peptide produced by strain T8. Plantaricin 423 
is similar to pentocin TV35b produced by Lactobacil/us pentosus TV35b (Okkers et al., 
1999), as deduced from plasmid DNA sequences (Dr C.A. van Reenen , Department of 
Microbiology, Stellenbosch University, personal communication) . Pentocin TV35b is also 
active against C. albicans (Okkers et al., 1999). Plantaricin 423, mundticin ST15 and 
bacteriocin T8 are 3.93, 3.94 and 5.07 kDa in size, respectively (de Kwaadsteniet et al., 
2005; van Reenen et al., 1998) . 
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L. plantarum 423, E. mundtii ST15 and strain T8 do not produce H20 2. Hydrogen peroxide 
producing LAB are killed by spermicides containing nonoxynol-9 (McGregor et al., 1990) . 
Spermicides serve as contraception and protect the urogenital tract of women against 
sexually transmitted pathogens such as Neisseria gonorrhoeae , Chlamydia trachomatis and 
HIV (Richardson , 2002) . Strains 423 , ST15 and T8 could be resistant to spermicides 
(Mclean and McGroaty, 1996) however, this resistance must be tested in in vivo 
experiments. 
Orally administered Lactobacillus rhamnosus GR-1, in combination with Lactobacillus 
fermentum RC-14, was effective in the treatment of bacterial vaginosis and converted the 
microflora in the urogenital tract to normal levels (Reid et al. 2001a ; 2001 b; 2003). Strains 
GR-1 and RC-14 are adherent to uro-epithelial and vaginal cells and inhibit the growth and 
adhesion of urogenital pathogens . L. rhamnosus GR-1 , a non-hydrogen peroxide producer, 
is resistant to spermicide. L. fermentum RC-14 produces H20 2 and is not resistant to 
spermicide (Reid et al. 1994, 1995). The potential application of L. plantarum 423, E. mundtii 
ST15 or strain T8 as urogenital probiotics will possibly be more efficient if taken in 
combination with H20 r producing lactic acid bacteria. 
The safety of E. mundtii ST15 and strain T8 must be thoroughly tested in in vivo studies. 
since their use as probiotics for human consumption is questionable. Some strains of 
Enterococcus spp. (such as E. faecalis) have been associated in nosocomial infections . 
Furthermore, some enterococci are resistant to glycopeptides and antibiotics , produce 
biogenic amines and exhibit virulence factors. In vivo studies will not only evaluate the safety 
of the three lactic acid bacteria, but also their efficiency and their ability to attach to uro-
epithelial cells (Franz et al., 1999; Moreno et al., 2005). 
Aggregation of E. mundtii ST15 and E. faecium TB to C. albicans may also inhibit C. albicans 
from adhering to epithelial cells. The fact that clinical strains of E. faecalis and C. albicans 
co-infect the urogenital tract of patients, (Bayo et al., 2002; Lifshitz et al., 1999; Reid et al., 
1992) renders the application of E. mundtii ST15, L. plantarum 423 and strain T8, or their 
bacteriocin -like peptides , even more attractive. 
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TABLE 1. Antimicrobial activity (Arbitrary units/ml ; AU/ML) of L. plantarum 423, E. mundtii 
ST15 and strain T8 against uropathogenic strains of Enterococcus faeca/is 
E. faeca/is E. faeca/is E. faeca/is E. faecal is E. faeca/is 
MDK1 MDK2 MDK3 MDK4 MDK5 
Supernatant 
Lb. plantarum 423 400 400 800 400 400 
E. mundtii ST15 1600 1600 3200 1600 1600 
Strain T8 400 400 400 400 400 
Partial purification 
Lb. plantarum 423 3200 3200 3200 12800 12800 
E. mundtii ST15 6400 6400 12800 12800 6400 
Strain T8 1600 1600 800 1600 1600 
Concentrated 
Lb. plantarum 423 51200 51200 51200 102400 102400 
E. mundtii ST15 204800 102400 102400 102400 51200 
Strain T8 6400 3200 6400 1600 1600 
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FLG 1. The two lactic acid bacteria strains (A: E. mundtii ST15 and C: strain T8) aggregated with Candida a/bicans. No aggregation took 
place between Lb. plantarum 423 and Candia albicans (8). 
\ 
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BACTERIOCIN TS, A NOVEL CLASS Ila SEC-DEPENDENT BACTERIOCIN 
PRODUCED BY ENTEROCOCCUS FAEC/UM TB, ISOLATED FROM VAGINAL 
SECRETIONS OF CHILDREN INFECTED WITH HIV 
M. de Kwaadsteniet , T. Fraser, C.A. van Reenen and L.M .T. Dicks 
Department of Microbiology, Stellenbosch University, Stellenbosch, South Africa 
Enterococcus faecium TB , isolated from vaginal secret ions of children with HIV, 
produces a class Ila sec-dependent bacteriocin different from other sec-dependent 
bacteriocins. Bacteriocin T8 is 5.07 kDa in size and active against strains of 
Enterococcus faecalis isolated from patients diagnosed with vaginosis , Lactobacil/us 
sakei and a Propionibacterium sp. The bacteriocin is heat stable (withstands 100°C 
for 60 min) and remains active in phosphate buffer from pH 4 to 10. The mode of 
activity is bactericidal , as determined against E. faecalis . The gene encoding the 
sec-dependent leader peptide and mature peptide with the conserved YGNG-motif, 
characteristic of class Ila bacteriocins, is located on a 7 kb plasmid . A second ORF 
(ORF2) encodes a potential immunity gene. A further two ORFs (ORF3 and 4) 
encoding a mobilization protein and a relaxase nuclease, respectively, were 
identified . 
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Bacteriocins are ribosomally transcribed peptides antimicrobial against closely 
related bacteria (Klaenhammer, 1993). Four classes of bacteriocins have been 
described based on their structural, chemical and functional properties 
(Klaenhammer, 1993). Peptides from classes I and II are heat stable. Small 
membrane-active, post-translational modified peptides containing lanthionine and 13-
methyl lanthionine are classified as !antibiotics and are grouped into class I 
(Klaenhammer, 1993). Class II bacteriocins differ from class I in that they do not 
undergo post-translational modification and they have an YGNGX2CX4CXV-
sequence at the N-terminal (Klaenhammer, 1993). Single-peptides (one-peptide 
bacteriocins) are grouped into class Ila. Typical examples of the latter are pediocin 
PA-1 , produced by Pediococcus acidilactici (Marugg et al., 1992); sakacin P, 
produced by Lactobacillus sakei (Tichaczek et al., 1994) ; plantaricin 423, produced 
by Lactobaci/lus plantarum 423 (van Reenen et al., 1998); and enterocin A, produced 
by Enterococcus faecium (Aymerich et al., 1996). Two-peptide bacteriocins are 
grouped into class llb. Large heat-labile bacteriocins are grouped into class Ill and 
complex bacteriocins into class IV (Klaenhammer, 1993). 
The majority of class Ila bacteriocins have a double-glycine sequence in the N-
terminal , which serves as recognition signal for peptide procession and secretion 
(Aymerich et al., 1996; Marugg et al., 1992; Tichaczek et al., 1994; van Reenen et 
al., 1998). ATP-binding cassette (ABC)- transporters translocate the bacteriocin 
across the cell membrane (Haverstein et al. , 1995). A few class Ila bacteriocins 
make use of a signal peptide instead of a double-glycine leader sequence (Cintas et 
al., 1997; Tomita et al., 1996). The leader peptide is usually positively charged and 
has a hydrophobic core and cleavage region . The peptide is processed by a signal 
peptidase during translocation across the cell membrane (von Heijne and 
Abrahmsen , 1989) . Enterocin P (Cintas et al., 1997) and bacteriocin 31 (Tomita et 
al., 1996) produced by Enterococcus faecium P13 and Enterococcus faecal is Y1717, 
respectively, are examples of sec-dependent class Ila bacteriocins. Other examples 
of sec-dependent peptides are enterolysin A, produced by Enterococcus faecalis 
LMG 2333 , classified as a large heat-labile class Ill peptide (Nilsen et al., 2003) and 
lactococcin 972, a two-peptide bacteriocin grouped into class llb (Martinez et al., 
1999). Two nonlantibiotics, divergicin A (Worobo et al., 1995) and acidocin B (Leer et 
al., 1995) are also secreted by a signal peptide. 
' The purpose of this study was to identify strain T8 and characterize bacteriocin its 
bacteriocin. 
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MATERIALS AND METHODS 
Bacterial strains and culture conditions. LAB were propagated in Mann Rogosa 
Sharpe (MRS) broth (Biolab, Diagnostics, Midrand, South Africa) at 37°C. The 
uropathogenic strains of Enterococcus faecalis were cultured in Brain Heart Infusion 
(BHI) broth (Biolab) at 37°C. Escherichia coli Bluescript and DH5a were cultured in 
Luria Bertani (LB) broth (Biolab) on a rotating wheel at 37°C. Other strains included 
in the test panel were from LMG (Laboratorium voor Microbiologie, University of 
Ghent, Belgium) and our own culture collection . Bacteria were stored at -80°C in 
40% (v/v) glycerol. 
Identification of strain TB. Strain T8 was identified to genus level by phenotypic 
characteristics (Holt, 1994) and to species level by 16S rDNA sequencing. DNA was 
isolated using the High Pure PCR Preparation Kit (Roche Diagnostics , Indianapolis, 
USA). DNA was amplified by PCR using the 16S rDNA primers and conditions 
described by Felske et al. (1997) . Amplified fragments were cloned into pGEM®-T 
Easy Vector Systems (Promega, Madison, USA). Constructs were transformed to E. 
coli DH5a. Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen®, 
Valencia, California, USA) and sequenced with an ABI Prism ™377 DNA Sequencer 
(PE Biosystems SA, Pty, Ltd) . All ligations and transformations were performed 
according to standard procedures (Ausubel , 1994). Homology with sequences in 
GenBank was determined by using the BLAST program (Altschul et al., 1997). 
Antimicrobial activity spectrum of bacteriocin TB. Enterococcus faecium T8 was 
cultured in 500 ml MRS broth (Biolab) for 24 h at 37°C. Cells were harvested 
(1 O 000 x g, 10 min , 4°C) and proteins precipitated from cell-free supernatants with 
80% saturated ammonium sulphate (Sambrook et al., 1989). The precipitate was 
collected by centrifugation (10 000 x g, 1 h, 4°C) and the pellet suspended in 10 ml 
ammonium acetate (pH 6.5) . The concentrated bacteriocin was dialysed against 4 I 
sterile distilled water using a Spectra-Par membrane with a 1000 Da cut-off 
(Spectrum Inc., CA, USA). Antimicrobial activity was determined by using the agar-
spot test method (Schillinger and Lucke, 1989) and the well-diffusion method (Tagg 
and McGiven, 1971). Activity of the crude extract was expressed in arbitrary units per 
ml (AU/ml) . One AU is defined as the reciprocal of the highest serial two-fold dilution 
, showing a clear zone of inhibition of the indicator strain (van Reenen et al., 1998). 
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The crude extract was used to determine the spectrum of antimicrobial activity and to 
characterize bacteriocin T8. 
Characterization of bacteriocin TS. One ml of the crude-extract of bacteriocin T8 
was incubated for 2 h at 37°C in the presence of 0.5 mg/ml (final concentration) 
amylase (Sigma Diagnostics, St. Louis, USA), Proteinase K (Roche Diagnostics 
Corporation , Mannheim, Germany), pronase (Boehringer Mannheim, GmbH, W-
Germany) and pepsin (Boehringer Mannheim), respectively. The enzymes were 
inactivated (10 min at 80 °C) and antimicrobial activity determined as described 
previously. Bacteriocin T8 crude extract not treated with enzymes was used as 
control (lvanova et al., 1998). 
In a separate experiment, the crude extract of bacteriocin T8 was adjusted to pH 
values ranging from 2.0 to 12.0 (increments of two pH units) with sterile 1 M NaOH or 
1 M HCI and incubated for 2 h at 37°C. The pH was then neutralized by slowly 
adding 1 M NaOH or 1 M HCI (lvanova et al., 1998) and tested for antimicrobial 
activity as described before. 
The cell-free supernatant of E. faecium TB was incubated at 60°C and 100°C for 10, 
30 and 90 min, respectively, and tested for antimicrobial activity as described 
previously. The control was cell-free supernatant of E. faecium T8 not subjected to 
heat treatment and kept at 8°C (lvanova et al., 1998). 
E. faecalis MDK2, isolated from patients diagnosed with vaginosis, was used as 
sensitive strain in all bacteriocin activity tests. 
The molecular size of bacteriocin T8 was determined by tricine-SDS-polyacrylamide 
gel electrophoresis (Schagger and von Jagow, 1987). One half of the gel was 
stained with Coomassie Blue R250 (Saarchem, Krugersdorp, South Africa) . The 
other half was pre-washed with sterile distilled water and overlaid with E. faecalis 
MDK2 (106 CFU/ml) to determine the position of bacteriocin T8 (van Reenen et al., 
1998). A Rainbow™ protein molecular weight marker, with fragments from 2.5 to 
45.0 kDa (Amersham International, UK) was used. 
Mode of action studies. Active growing cells of E. faecalis MDK2 were inoculated 
(0.2%, v/v) into BHI broth and incubated for 5 h at 37°C to mid-exponential growth. 
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Bacteriocin TB crude-extract (6400 AU ml"1) was added to the culture and cell density 
readings recorded at 600 nm, hourly for B h (lvanova et al., 199B). The control was 
autoclaved (15 min at 121 °C). 
Plasmid curing. Active-growing cells of E. faecium TB were inoculated into MRS 
broth, supplemented with acridine orange (Merck) , novobiocin (Sigma) and SOS 
(Sigma) , respectively (Ruiz-Barba et al., 1991). The components were added at 0.5, 
1.0, 2.0, 3.0, 4.0 and 5.0% (m/v) increments , respectively. After 1 B h of incubation at 
37°C, cells from each treatment were plated onto MRS agar and incubated for a 
further 1 B h. Colonies were replica-plated onto MRS agar and one set overlaid with 
E. faecalis MDK2 embedded into 1 % (m/v) soft agar (106 cfu/ml). The plates were 
incubated for 1B h at 37°C. Colonies with no inhibition zones were identified. 
Corresponding colonies were selected from replica plates, inoculated into MRS broth 
and incubated for 1B hat 37°C. The cells were harvested (10 000 x g, 10 min , 4°C) 
and plasmid DNA was isolated using the Qiagen® Plasmid Midi Kit. Bacteriocin-
producing cells of E. faecium TB were used as control. 
Sequencing of plasmid TS. Plasmid DNA isolated from E. faecium TB was digested 
with Hindlll (Roche) and ligated with T4 Ligase (Roche) into pBluescript SK(+/-) 
(lnvitrogen, Paisley , UK) . Constructs were transformed to E. coli DH5 cx., according to 
the method of Ausubel (1994). DNA was isolated from the transformants by using 
the QIAprep Spin Mini prep Kit (Qiagen). Primers designed from M13 (pBluescript) 
were used to sequence the first DNA fragment of pTB. Primers designed from the 
latter sequence (Table 1, MDK1 a and MDK1 b) were used to amplify the DNA 
fragment and was then cloned into pGEM®-T Easy Vector Systems (Promega). The 
constructs were transformed to E. coli DH5cx.. The DNA was isolated as described 
previously. Subsequent primers (MDK2a and MDK2b, Table 1,) were designed from 
amplified DNA fragments and the plasmid sequenced by primer-walking . 
RESULTS 
Antimicrobial activity spectrum of bacteriocin TS. Bacteriocin TB inhibited 
uropathogenic Enterococcus faecalis strains, a Lactobacil/us sp., two Enterococcus 
' spp. and a Propionibacterium sp. (Table 2) . 
Identification of E. faecium TS. E. faecium TB was morphologically related to 
Enterococcus sp. and revealed 94% 16S rDNA homology with Enterococcus faecium 
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strain SF3 ( gi1554423SS lgb1AY73540S.1 I) . The ability of the isolate to ferment glycerol 
and melibiose classified the isolate as E. faecium (Holt, 1994) . 
Characterization of bacteriocin TS and mode of action studies. Bacteriocin TS 
was sensitive to Proteinase K, pepsin and pronase (Table 3). Treatment with 
amylase had no effect on bacteriocin activity. No activity was recorded at pH 2 and 
12, and after 90 min at 100°C. The mode of action is bactericidal as observed in Fig. 
1. According to tricine-SDS-PAGE, the molecular size of bacteriocin TS is between 
3.5 and 6.5 kDa (Fig . 2) . 
Plasmid curing and sequencing. No loss in bacteriocin activity was recorded when 
E. faecium TS was incubated in the presence of acridine orange or novobiocin . 
However, growth was impaired in the presence of 3% (m/v) SDS, accompanied by a 
complete loss in bacteriocin TS activity. 
Two plasmids were isolated from E. faecium TS. Growth in the presence of 3% (m/v) 
SOS resulted in the loss of the smaller 7 kb plasmid (Fig. 3) . Sequencing of plasmid 
TS revealed four open reading frames (ORFs) (Fig. 4) . The first ORF encodes a 74-
amino acid peptide, the bacteriocin precursor. The start codon (ATG) is preceded 9 
bp upstream by a potential Shine-Dalgarno ribosome-binding site (AAAGGA; 
underlined) and S3 bp upstream by a potential -10 consensus promoter region 
(Pribnow box; TATAAT; underlined), as indicated in Fig . 5. The first ORF (ORF 1) of 
222 bp encodes the pre-bacteriocin (leader peptide and pro-bacteriocin) . The leader 
peptide contains a potential signal peptidase-processing site (VOA) from position S2 
to 90 (double underlined). A conserved YGNG-sequence is located at position 100 
to 111 (boxed). Two cysteine residues (positions 118 to 120 and 133 to 135) and a 
valine residue (position 49 to 51) are also conserved (boxed) . The center of the 
signal peptide is hydrophobic (Fig . 6A) conforming to the rules of signal peptides (von 
Heijne and Abrahmsen , 1989) . The mature peptide is overall hydrophilic with minor 
hydrophobic peaks (Fig . 68). 
The second ORF (ORF 2) is preceded 10 bp upstream by a potential Shine-Dalgarno 
ribosome-binding site (AGGGAG; underlined), as indicated in Fig . 5. ORF 2 encodes 
'a 95-amino acid peptide, which resembles an immunity protein. ORF3 encodes a 
mobilization protein that has 96% homology to the mobilization protein of E. faecium 
DO (gil 6S194353I gbl EAN08S64.1 I). ORF4 encodes a relaxase mobilization 
nuclease domain that has 75% homology with E. faecium DO 
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(gil 681943491 gbl EAN08860 .11 ). ORF4 is located immediately downstream of the 
mobilization gene. 
DISCUSSION 
Bacteriocin T8 is inactivated by proteolytic enzymes, but not by amylase. This 
suggests that the peptide is either not glycosylated or that its activity is not influenced 
by glycosylation. According to its size (5.07 kDa) and stability to heat (100°C for 60 
min), bacteriocin T8 belongs to class Ila group of bacteriocins. 
Bacteriocin T8 is different from the normal class Ila bacteriocins in having a sec-
dependent leader signal peptide (Fig. 5 and 7). As far as we could determine, this is 
the fourth description of a class Ila sec-dependent bacteriocin described and the fifth 
description of a sec-dependent bacteriocin produced by a species of the genus 
Enterococcus. The other class Ila sec-dependent bacteriocins are enterocin P, 
produced by Enterococcus faecium P (Cintas et al., 1997) , bacteriocin 31 , produced 
by Enterococcus faecalis Y1717 (Tomita et al., 1996) and an enterocin P-like 
bacteriocin produced by E. faecium GM-1. The latter bacteriocin differs from 
enterocin P and bacteriocin 31 in being active against Gram-positive and Gram-
negative bacteria (Kang and Lee, 2005). E. faecalis LMG 2333 produces a sec-
dependent class Ill bacteriocin (Nilsen et al., 2003) . 
The narrow spectrum of activity recorded for bacteriocin T8 is typical for many other 
class Ila bacteriocins . Bacteriocin 31 also has a narrow spectrum of activity and 
inhibits only Listeria monocytogenes, E. faecalis and Enterococcus hirae (Tomita et 
al., 1996). Enterocin P and the enterocin P-like substance have a broader spectrum 
of activity. Enterocin P inhibits L. monocytogenes , Staphylococcus aureus , 
Clostridium spp., Lactobacillus spp., Pediococcus spp., Enterococcus spp. and 
Propionibacterium spp. (Cintas et al., 1997). The mode of activity of bacteriocin T8 is 
bactericidal , similar to that recorded for enterocin P (Cintas et al., 1997). 
The genes encoding bacteriocin T8 are located on one plasmid. The structural gene 
encodes a sec-dependent leader peptide with three positively charged amino acids 
· (Figs 5 - 7) , a number of hydrophobic amino acids (Figs 5 - 7) and a cleavage region 
(Figs 5 - 7) . Two small hydrophobic amino acids are positioned adjacent to the 
cleavage site (VOA) . Conforming to the definition of a typical signal peptide (von 
Heijne and Abrahmsen, 1989), similar to other sec-dependent bacteriocins. Typical to 
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class Ila bacteriocins, bacteriocin TS has a conserved YGNGX2CX4CXV-motif (Fig. 5 
and 7) . Deduced from the DNA sequence, the molecular weight of bacteriocin TS is 
5.1 kDa and similar to the 5.0 kDa recorded for bacteriocin 31 (Cintas et al., 1997) 
but larger than the 4.6 kDa reported for enterocin P (Tomita et al., 1996). On amino 
acid level , bacteriocin TS is 69% homologous to bacteriocin 31 and 47% to enterocin 
P (Fig . 7) 
The second ORF encodes a potential immunity protein that has a calculated 
molecular weight of 10.S9 kDa (Fig 5) . The gene is located immediately downstream 
of the structural gene. This is a common feature of LAB bacteriocins (Nes et al. , 
1996). The protein is only 50% homologous to the immunity protein of bacteriocin 
31 . The immunity protein of bacteriocin 31 consists of 94 amino acids and has a 
molecular weight of 11 .0 kDa (Cintas et al., 1996). No homology has been detected 
with any other immunity proteins listed in GenBank. 
The mobilization protein and relaxase mobilization nuclease domain are presumably 
involved in the transfer of the plasmid during conjugation . Mobilization genes in 
enterococci are often located on the same gene cluster as the structural genes of 
their bacteriocin , as observed for enterocins 1071A and 10718. (Balla and Dicks, 
2005) . The genes encoding bacteriocins of enterococci are known to be associated 
with pheromone-responsive conjugative plasmids (Masqueda et al., 2004 ; Nakayama 
et al., 1995; Sanchez-Hidalgo et al., 2003) . Secretion of specific peptide sex-
pheromones by recipients initiates cell aggregation and conjugation (Clewell, 1993; 
Clewell et al., 2002) . The genes encoding bacteriocin 31 are also located on a 
pheromone-responsive conjugative plasmid (Tomita et al., 1996). 
Although bacteriocin TS and bacteriocin 31 share certain characteristics , the two 
peptides are structurally different (69% homology on amino acid level). The low 
homology recorded between the signal peptides and immunity proteins of the two 
strains is further proof that bacteriocin TS is different from bacteriocin 31 and all other 
bacteriocins thus far described for enterococci. 
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Primer 
M13F 
M13R 
MDK1(a) 
MDK1(b) 
MDK2(a) 
MDK2(b) 
TABLE 1. Primers used in this study 
Sequence 
GTTTTCCCAGTCACGAC 
CAGGAAACAGCTATGAC 
GTGTGTATTGCACCACTTAG 
GAGGTTCAAGACAACTATGAG 
GGATAGGCGACAAGTTATTA 
TCGGTGAAATTGTTGCAAAT 
TABLE 2. S~ectrum of antimicrobial activitzi of bacteriocin TB 
Microorganism Strain* Growth Growth 
conditions medium 
Enterococcus faecalis MDK1 37 °C aerobic BHI 
Enterococcus faecalis MDK2 37 °C aerobic BHI 
Enterococcus faecalis MDK3 37 °C aerobic BHI 
Enterococcus faecalis MDK4 37 °C aerobic BHI 
Enterococcus faecalis MDK5 37 °C aerobic BHI 
Lactobacillus acidophilus LMG 13550 37°C anaerobic MRS 
Lactobacillus bulgaricus LMG 13551 37°C anaerobic MRS 
Lactobaci/lus casei LMG 13552 37°C anaerobic MRS 
LHS3 37 °C aerobic MRS 
Lactobacillus curvatus LMG 13553 30°C anaerobic MRS 
DF38 37 °C aerobic MRS 
Lactobacil/us fermentum LMG 13554 37°C anaerobic MRS 
Lactobacillus helveticus LMG 13555 42°C anaerobic MRS 
Lactobacillus plantarum LMG 13556 37°C anaerobic MRS 
Lactobacillus reuteri LMG 13557 37°C anaerobic MRS 
Lactobacillus sake LMG 13558 30°C anaerobic MRS 
Lactobacillus salivarius 241 37 °C aerobic MRS 
Pediococcus pentosaceus LMG 13560 30°C anaerobic MRS 
LMG 13561 30°C anaerobic MRS 
Leuconostoc cremoris LMG 13562 30°C anaerobic MRS 
LMG 13563 30°C anaerobic MRS 
Streptococcus thermophilus LMG 13564 42°C anaerobic MRS 
LMG 13565 42°C anaerobic MRS 
Enterococcus faecalis LMG 13566 37°C aerobic BHI 
BFE 1071 37 °C aerobic MRS 
Staphylococcus carnosus LMG 13567 37°C aerobic BHI 
Listeira innocua LMG LMG 13568 30°C aerobic BHI 
Bacillus cereus LMG 13569 37°C aerobic BHI 
Clostridium sporogenes LMG 13570 37°C anaerobic RCM 
Clostridium tyrobutyricum LMG 13571 30 °C anaerobic RCM 
Propionibacterium sp. LMG 13574 32 °C anaerobic GYP 
78 
Bacteriocin 
act iv it}'. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
* LMG codes depicts isolates from Laboratorium voor Microbiologie , University of 
Ghent, Belgium; remaining those of our own culture collection 
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TABLE 3. The effect of enzymes, pH and temperature on the activity of 
bacteriocin T8 
Treatment 
Enzymes (O.Smg/ml) 
amylase 
pepsin 
pronase 
Proteinase K 
Bacteriocin activity 
+ 
control (not treated with enzymes, at 30 °C) + 
pH 
2 
4; 6; 8; 10 + 
12 
control (pH not adjusted , at 30 °C) + 
Temperature 
10, 30 and 90 min at 30° C + 
10, 30 and 90 min at 60° C + 
10 and 30min at 100°C + 
90 min at 100°c 
control (bacteriocin at 4 °C) + 
79 
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FIG. 1. Cell lysis of E. faecalis MDK2 following addition of bacteriocin TB at 
mid-exponential phase (5 hours). 
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FIG. 2. Separation of partially purified bacteriocin TB by SOS-PAGE. Lane 1, 
Rainbow protein size marker (Amersham); lane 2, bacteriocin TB stained with 
Coomassie blue R-250; lane 3, bacteriocin TB overlaid with cells of E. faecalis MDK2 
embedded in BHI soft agar (1%). The circle indicates the inhibition zone. 
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1 2 3 
FIG. 3. Agarose gel showing curing of the plasmid of E. faecium TB. Lane 1: A. 
marker, lane 2: plasmid DNA isolated from strain TB (not cured), and lane 3: Loss of 
plasmid DNA after curing of strain TB. The arrow indicates plasmid loss. 
ORF1 ORF2 
FIG. 4. Gene cluster of the bacteriocin determinants located on plasmid TB (pTB). 
ORF1 encodes a bacteriocin precursor; ORF2 a potential immunity protein; ORF3 a 
mobilization protein and ORF4 a relaxase nuclease. 
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-10 
TGTTATATAATAAAATTACTAAGATTATTTAATATAACAAGCAATTTTAAAAAAACGAAA 
S.D. ORF1 
AGGAAAAACAATCATGAAAAAGAAAGTATTAAAACATTGTGTTATTCTAGGAATATTAGG 
M K K K V L K H C V I L G I L G 
AACTTGTCTAGCTGGCATCGGTACAGGAATAAAAGTTGATGCAGCTACTTlACT ATGGAA~ 
T C L A G I G T G I K V D A A T Y Y G N 
~TTTATTGTAACAAAGAAAAATGTTGGGTAGATTGGAATCAAGCTAAAGGAGAAAT 
G L Y C N K E K C W V D W N Q A K G E I 
TGGAAAAATTATTGTTAATGGTTGGGTTAATCATGGTCCATGGGCACCTAGAAGGTAGTG 
G K I I V N G W V N H G P W A P R R 
S.D. ORF2 
GTAGGGAGGTTATTATAATGGATTTTACTAAAGAAGAAAAACTTTTAAATGCAATTAGTA 
M D F T K E E K L L N A I S 
AAGTATACAATGAAGCAACTATAGATGACTATCCTGACTTAAAAGAAAAGCTCTTTCTTT 
K V Y N E A T I D D Y P D L K E K L F L 
ATTCTAAAGAAATCAGTGAGGGAAAAAGTGTTGGTGAAGTTAGTATGAAATTAAGTAGTT 
Y S K E I S E G K S V G E V S M K L S S 
TTCTTGGAAGATATATTTTAAAACATAAATTTGGATTACCTAAATCTTTAATAGAATTAC 
F L G R Y I L K H K F G L P K S L I E L 
AAGAAATTGTTAGTAAGGAATCTCAAGTATATAGAGGATGGGCTTCTATTGGTATTTGGA 
Q E I V S K E S Q V Y R G W A S I G I W 
GTTAATTCTTTGGAATAAAATGAAAATGGGACTGAAGAATCAATTCTGATTCATCAGTCC 
s 
82 
FIG. 5. Nucleotide sequence of the bacteriocin region and the deduced amino 
· acid sequence. The -10 promotor box and the Shine-Dalgarno (S.D.) ribosome 
binding sequences are underlined. ORF1 encodes the structural gene of bacteriocin 
T8 and ORF2 the potential immunity gene. 
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FIG. 6. Hydrophobicity profiles of the leader peptide (A) and the mature 
bacteriocin (B). 
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i ii iii 
~ 
Enterocin P MRKKLFSLALIGI- -- FGLVVTNFGT KVDA 
Bacteriocin 31 MKKKVICGIIGIG------- FTALGTNVEA 
Bacteriocin TS MKKKVLKHCVILGILGTCLAGIGTGI KVDA 
(A) 
84 
27 
24 
30 
Enterocin P 
Bacteriocin 31 
Bacteirocin TS 
Consensus 
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH 44 
ATYYGNGLYCNKQKCWVDWNKASREIGKIIVNGWVQHGPWAPR 43 
ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR 44 
YYGNG YCN KCWV W A I I GW 
(B) 
FIG. 7. Comparison of amino acid sequences of the N-terminals of class Ila 
sec-dependent bacteriocins. Data for enterocin P and bacteriocin 31 were obtained from 
Cintas et al. (1997) and Tomita et al. (1996) , respectively . 
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GENERAL DISCUSSION AND FINAL CONCLUSIONS 
Probiotic lactic acid bacteria may be used to treat urogenital infections. Lactobacillus 
rhamnosus GR-1 and Lactobacillus fermentum RC-14 reversed the microflora of patients 
suffering from bacterial vaginosis to normal cell numbers (Reid et al., 2001 ; Reid et al. , 2003). L. 
fermentum CRL 1058 protected mice against uropathogenic E. coli, a causative agent of urinary 
tract infections (Nader de Macias et al., 1996). The ingestion of Lactobaci/lus acidophi/us 
NFCM™ reduced the number of candidal and bacterial vaginosis infections (Collins and Hardt 
1980; Hallen et al. , 1992; Hilton et al., 1992; Shalev et al., 1996). Bacteriocins produced by 
various lactic acid bacteria inhibit uropathogens such as G. vagina/is, E. coli, N. gonorrhoeae 
and clinical E. faecalis strains (Aroutcheva et al., 2001 ; Morency et al., 2001 ; Ocana et al., 1999; 
Simoes et al., 2001) . 
Bacteriocin ST15, plantaricin 423 and bacteriocin T8 produced by Enterococcus mundtii ST15, 
Lactobaci/lus p/antarum 423 and Enterococcus faecium T8, respectively , displayed antimicrobial 
activity against uropathogenic strains of E. faeca/is and C. a/bicans. Bacteriocin ST15 was the 
most effective , followed by plantaricin 423. Although bacteriocin T8 displayed low antimicrobial 
activity , the specificity of the peptide is higher than that recorded for of plantaricin 423, i.e. has a 
narrower activity spectrum (van Reenen et al., 1998). The high specificity of bacteriocin T8 and 
bacteriocin ST15 towards lactobacilli may be advantageous, since they will not cause a rapid 
decline in the natural microflora of the urogenital tract (Altoparlak et al., 2004; Hillier et al., 1993; 
Klebanoff et al., 1991 ). 
The probiotic properties of E. mundtii ST15, Lb. plantarum 423 and E. faecium T8 were further 
investigated. All three bacteria produce lactic acid but not H20 2. This may be an advantage, 
since H20 r producers are susceptible to the spermicide, nonoxynol-9 (McGregor et al. 1990). 
Furthermore, E. mundtii ST15 and E. faecium T8 co-aggregated with a clinical strain of C. 
albicans and can thereby inhibit the growth of C. a/bicans. 
A novel class Ila sec-dependent bacteriocin, T8, was identified and characterized . The producer 
strain, T8, revealed 94% 16S rDNA homology with Enterococcus faecium and Enterococcus 
durans. However, strain T8 ferments glycerol and melibiose and is thus more closely related to 
E. faecium (Holt, 1994). Bacteriocin T8 is a heat stable protein and is active against 
Lactobacillus sakei, E. faeca/is and a Propionibacterium sp. The mode of activity is bactericidal. 
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The bacteriocin determinant is located on a plasmid and consists of two ORFs. The first ORF 
encodes a 7 4 amino acid bacteriocin precursor that consists of a leader signal peptide and a 
mature peptide. The leader peptide fulfills Von Heijne's rules for a signal peptide, namely three 
positively charged amino acids, a span of hydrophobic amino acids and a cleavage region 
(VOA) (von Heijne and Abrahmsen, 19B9). The conserved YGNGX2C~CXV-sequence , typical 
of all class Ila bacteriocins, is present in the mature peptide. The mature peptide has a 
theoretical molecular weight of 5.07 kDa. This corresponds to the tricine-SDS-PAGE where the 
partially purified peptide is between 3.5 and 6.5 kDa in size. The second ORF encodes a 
potential immunity protein and is located immediately downstream of the structural gene. 
Bacteriocin T8 has 69% amino acid similarity with bacteriocin 31 and 47% with enterocin P, 
respectively. Bacteriocin 31 , enterocin P and enterocin P-like bacteriocin , produced by E. 
faecium P (Cintas et al., 1997), E. faecalis Y1717 (Tomita et al., 1996) and E. faecium GM-1 
(Kang and Lee, 2005), are, to our knowledge , the only three sec-dependent class Ila 
bacteriocins thus far described. 
A mobilization protein and relaxase mobilization nuclease domain is located on the same 
plasmid as the bacteriocin operon. Production of bacteriocins by enterococci is associated with 
pheromone-responsive conjugative plasmids (Clewell , 1993; Clewell et al., 2002). Bacteriocin 31 
is encoded on a pheromone-responsive conjugative plasmid (Tomita et al., 1996). 
Future research is needed to optimize the production of bacteriocin T8. The problem can be 
approached in two different ways. Optimizing growth and bacteriocin production conditions of E. 
faecium TB can increase the production of bacteriocin TB, as observed in the case of the sec-
dependent class Ill bacteriocin , enterolysin A (Nilsen et al., 2003). The alternative is to clone the 
bacteriocin structural gene into a bacterium or yeast that is already used in the pharmaceutical 
industry for large-scale production of proteins (Gutierrez et al. , 2005). It is interesting to note that 
active enterocin P was detected after the structural gene of the sec-dependent bacteriocin was 
cloned into Pichia pastoris. All other attempts with bacteriocins secreted with ABC-transporters 
delivered poor results (Beaulieu et al., 2005; Schoeman et al., 1999; van Reenen et al., 2002) . 
The bacteriocins were detected in the supernatants, but at very low levels. 
The adhesion of Lb. plantarum 423, E. mundtii ST15, and E. faecium TB to uro- and vaginal 
epithelial cells will have to be studied with cell lines and in clinical trails . Similar studies have 
been conducted by Lee (2005) , Reid et al. (2001) and Fichorova et al. (2001 ). 
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In vivo studies are needed to conclude if the selected lactic acid bacteria are safe to be 
consumed and whether they can serve as an effective probiotic for women. The safety of E. 
mundtii ST15 and E. faecium T8 must be thoroughly investigated because of the pathogenic 
behaviour of certain enterococci (Franz et al., 1999; Moreno et al., 2005) . Developing a 
microbicidal gel containing only the active bacteriocin is an alternative to the use of the bacteria 
as urogenital probiotics for treating and preventing urogenital tract infections. 
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FIG. 1. Cell lysis of E. faecalis MDK2 following addition of bacteriocin T8 at 
mid-exponential phase (5 hours). 
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FIG. 2. Separation of partially purified bacteriocin T8 by SOS-PAGE. Lane 1, 
Rainbow protein size marker (Amersham); lane 2, bacteriocin T8 stained with 
Coomassie blue R-250; lane 3, bacteriocin T8 overlaid with cells of E. faecalis MDK2 
embedded in BHI soft agar (1%). The circle indicates the inhibition zone. 
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